The Investigation of Sirtuin Activities on Short-Chained Mono-Acylated Histone H3 Tetramers and Nucleosomes by Hsu, Willie Weili
  
THE INVESTIGATION OF SIRTUIN ACTIVITIES ON SHORT-CHAINED MONO-
ACYLATED HISTONE H3 TETRAMERS AND NUCLEOSOMES 
 
A Dissertation 
by 
WILLIE WEILI HSU  
 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
Chair of Committee,  Wenshe R. Liu 
Committee Members, Frank M. Raushel 
 Christian Hilty 
 Vijayanagarm Venkatraj 
Head of Department, Simon W. North 
 
August 2017 
 
Major Subject: Chemistry 
 
Copyright 2017 Willie Weili Hsu
 ii 
 
ABSTRACT 
 
 Lysine acylation serves as an epigenetic marker for myriad cellular processes, such 
as signaling, differentiation, DNA repair, angiogenesis, and the like. Sirtuin 1 (SIRT1) 
and Sirtuin 2 (SIRT2) are NAD+-dependent histone deacylases that operate as 
posttranslational regulators of lysine acylation states. Despite being a topic of increasing 
interest, little effort has been made to completely understand the overall character of 
these two sirtuin enzymes. Most of the studies have also been on the peptide level and 
not on actual sirtuin substrates (i.e. histone H3/H4 tetramers and nucleosomes). Thus the 
demand for systematic studies of enzymatic activities on native substrates for SIRT1 and 
SIRT2 is currently needed. 
 In this dissertation, we discuss the ability for SIRT1 and SIRT2 to deacylate 
various short-chain acylations—acetylation, crotonylation, and butyrylation—from 
lysine residues on the tetramer and nucleosome substrates. In addition, we explore the 
difference in selectivity between using peptide and nucleosome substrates with sirtuins. 
We find that SIRT1 and SIRT2 demonstrate relatively no substrate specificity across the 
screened histone H3 sites, contrary to previous expectations.  
 The implication of the overall non-specificity of SIRT1 and SIRT2 on the tetramer 
and nucleosome substrates suggests that these sirtuin enzymes have an adaptive nature, 
harnessing an ability to respond to various cellular situations, rather than an enzyme 
specifically designed for a particular task or function. 
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NOMENCLATURE 
 
Acetyl-CoA Acetyl coenzyme A 
AcK 𝑁ε-Acetyl-L-lysine 
ACSS2 Acyl-coenzyme A synthetase short-chain family member 2 
ATP Adenosine triphosphate 
APC/C Anaphase-promoting complex 
BAX bcl-2-like protein 4 
BuK 𝑁ε-Butyryl-L-lysine 
Butyryl-CoA Butyryl coenzyme A 
CAF-1 Chromatin assembly factor-1 
CBP CREB-binding protein 
CrK 𝑁ε-Crotonyl-L-lysine 
Crotonyl-CoA Crotonyl coenzyme A 
ELISA Enzyme-linked immunosorbent assay 
EPL Expressed protein ligation 
GNAT Gcn5-related N-acetyltransferases 
HATs Histone acetyltransferases 
HDACs Histone deacetylases 
Ku70 Lupus Ku autoantigen protein p70 
MYST MOZ, Ybf2, Sas2, Tip60 family 
NAD+ Nicotinamide adenine dinucleotide 
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ncAAs Noncanonical amino acids 
NCL Native chemical ligation 
Ni-NTA Nickel nitrilotriacetic acid 
P300 E1A binding protein p300 
PTMs Posttranslational modifications 
QM/MM Quantum mechanics/molecular mechanics  
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Sir2 Yeast sirtuin 2 
SIRT Sirtuin 
SPPS Solid phase peptide synthesis 
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CHAPTER I  
INTRODUCTION 
 
Histones 
In eukaryotes, 147 bp of chromosomal DNA is wrapped and organized 1.7 times 
around the histone octamer to form the nucleosome. Each histone octamer contains a 
pair of histone H2A, H2B, H3, and H4 proteins (Figure I-1). Each nucleosomal unit is 
linked together to form a beads-on-a-string structure called chromatin.1 The four histone 
proteins have a similar helix-turn-helix structure and a long N-terminal tail that lacks any 
defined secondary structure. All four histone proteins are the target of numerous, strictly 
regulated posttranslational modifications, such as acetylation, methylation, 
crotonylation, butyrylation, sumoylation, ubiquitination, and myriad other acylations. 
These modifications have the ability to alter nucleosomal stability and chromatin 
compaction, as well as, the ability to act as effectors of downstream cellular functions.2-6 
Over the past decades, much progress has been made in the identification of new 
posttranslational modifications on histones as well as the enzymes involved in their 
modification; however, histones were not always viewed with such scrutiny as they are 
today. After its discovery in 1884 by Albrecht Kossel, histones remained largely 
dismissed by the scientific community as a static source for DNA packaging. It was not 
until the late 20th century when a study found that transcription would not initiate on the 
nucleosome; however, if transcription were initiated before reaching the nucleosomal 
core, the process of transcription would proceed normally while displacing the histones  
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Figure I-1. Crystal structure of the histone octamer. Histone H2A is denoted in green, 
H2B in red, H3 in cyan, and H4 in magenta. PDB: 1KX5 
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from the DNA during the course of transcription.7 A companion study later 
demonstrated a similar repressing effect on the nucleosome in vivo.8 From there, the 
nucleosome began to find acceptance in the scientific community as a general gene 
repressor, rather than as an inert DNA packing complex. And eventually, with the 
discovery of histone-modifying enzymes, such as Gcn5 and Sir2 in yeast, the link 
between the nucleosome and posttranslational modifications was drawn.  
In the following decades, scientists have discovered that the nucleosome is the 
core to many diverse and complex cellular functions in the cell, including an active part 
in cell repair, gene transcription and repression, cell signaling, chromatin remodeling, 
DNA replication, and the like.2-6  
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Posttranslational Modifications 
With some exceptions, the twenty canonical amino acids are the building blocks 
of all eukaryotes; however, it is well known that to meet the complexity and rigors of the 
eukaryotic cell, these amino acids need to undergo chemical modifications termed 
posttranslational modifications (PTMs).9 These modifications grant proteins the ability 
to be involved in basic cellular and metabolic functions as well as cellular localization. 
These PTMs range from short to long chain acylations, three different stages of 
methylation, small molecule acylation, and more.10-12 It is well known that these PTMs 
are reversible and tightly regulated in cellular systems to maintain cell growth and 
health.6, 13-16 Lysine posttranslational modifications are the most prominent PTM in 
living cells, where the side-chain amino group can undergo a variety of acylations 
(Figure I-2). Herein, we will discuss the importance and presence of the various lysine 
acylations in more detail. 
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Figure I-2. Protein lysine acylation. 
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Protein Lysine Acetylation 
Protein lysine acetylation is one of the most prominent posttranslational 
modifications found in vivo. Acetylation occurs in cell via the catalytic transfer of the 
acetyl group from an acetyl coenzyme A (acetyl-CoA) molecule onto the side-chain 
amino group of lysine residues via histone acetyltransferases (HATs). One of the major 
roles of protein acetylation is its role in the translocation of newly synthesized histones 
from the cytoplasm to the nucleus via specific acetylation patterns. During the S phase of 
the cell cycle, newly synthesized histone H3 and H4 are produced while older histone 
H3/H4 tetramers are marked for degradation.17-20 These newly synthesized histone H3 
and H4 proteins are then acetylated at various specific sites (depending on species) that 
act as a signal for them to be taken for assembly into nucleosome. One such example is 
the function of human chromatin assembly factor-1 (CAF-1), which can freely pass 
between the cytoplasm and nucleus. CAF-1 detects and binds to newly synthesized 
histone H3 and H4 proteins, likely in the tetrameric form, in the cytoplasm and deposits 
the histones onto DNA in the nucleus.21 An interesting feature of CAF-1 is its ability to 
recognize the difference between new histone H3 and H4 from its mature counterpart.22 
This is likely due to differences in specific acetylation patterns on the histone proteins. 
Once the nucleosome has been formed, these acetylation patterns are then deacetylated 
by histone deacetylases (HDACs) and modified with new posttranslational modification 
patterns to utilize them for various cellular processes.  
Another critical role of protein acetylation is its role in regulating chromatin 
compaction. Chromatin exists in two states: euchromatin and heterochromatin (Figure I-
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3). The term euchromatin is defined as the state in which chromatin is loosely packed 
whereas heterochromatin is characterized by the tightened chromatin state. The 
conversion of lysine to acetyllysine via a histone acetyltransferase is known to alter the 
electrostatic interactions between the lysine amino side-chain and DNA. In a study by 
the Ottesen group, they were able to demonstrate the DNA loosening affect of acetylated 
histone H3 lysine 56 (H3K56ac) on the nucleosome structure.23, 24 Histone H3K56ac is a 
known site on the core region of the nucleosome that very closely interacts with the 
DNA unlike most of the other lysine sites on histone H3, which are located on the very 
flexible and unstructured N-terminal tail. However, the acetyl group is not solely the 
source of changing euchromatin to heterochromatin and vice versa. The acetylation 
marker acts as a signal (in conjunction with other specific PTMs) for nucleosome 
remodeling complexes to bind to the nucleosome region. The acetyllysine contributes by 
repelling the DNA enough to create space for the remodeling complexes to dock onto 
that region, where an unmodified lysine cannot accommodate that demand.  
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Figure 1-3. Chromatin in two states: heterochromatin and euchromatin. 
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Histone H4 is unique in its contribution to chromatin compaction via a single 
acetylation site histone H4K16ac.25 When considering the structure of chromatin, the N-
terminal tail of histone H4 rests in the acidic region of a neighboring histone H2A/H2B 
dimer via hydrogen bonds and salt bridges, which consists of six histone H2A and two 
histone H2B residues.26-28 Acetylation at histone H4K16 negates the interactions in this 
region and forces chromatin to begin to loosen slightly. In subsequent studies, deletion 
of the histone H4 N-terminal tail (residues 1-19) demonstrated a similar chromatin state, 
suggesting that histone H4K16 is vital for chromatin compaction, whereas H4K16ac is a 
hallmark for chromatin loosening.25 In addition, in vitro reconstitution of nucleosome 
arrays with histone H4K16ac demonstrated no difference from the nucleosome array 
with the N-terminal tail of histone H4 deleted. 
  The transfer of the acetyl moiety from acetyl-CoA to a lysine residue is catalyzed 
by histone acetyltransferases (HATs), and the removal of the acetyl moiety from 
acetyllysine is catalyzed by histone deacetylases (HDACs). Histone acetyltransferases 
are generally categorized into two families—the Gcn5-related N-acetyltransferase 
(GNAT) family and the MOZ, Ybf2, Sas2, Tip60 (MYST) family. Other 
acetyltransferases that do not fit in these two families due to either larger or mutated 
variants of the HAT domain, such as p300, CBP, and Rtt109 are placed in an unlabeled 
category.29 These categorizations are mainly based on sequence homology and shared 
structural features. One major difference between the GNAT and MYST family is the 
catalytic residues involved in the acetyltransferase mechanism (Figure I-4 & I-5). 
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Figure I-4. GNAT family acetyltransferase mechanism. 
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The family of Gcn5-like acetyltransferases has a conserved glutamate residue in 
the active site that serves to active a nearby water molecule that then activates the lysine 
substrate for the nucleophilic attack on an acetyl-CoA molecule.30 Following the 
collapse of the tetrahedral intermediate, one free CoA molecule and acetylated lysine 
residue is afforded. The catalytic core of the MYST family has a conserved glutamate 
residue as well; however, this family of enzymes also has a conserved Zn2+-binding site 
and a cysteine rich region, which are involved in the catalytic mechanism. The MYST 
family’s acetyltransferase mechanism involves a ping-pong mechanism where acetyl-
CoA first binds to the active site pocket where is undergoes nucleophilic by a cysteine 
residue, creating a transient acetylated cysteine residue and one free CoA molecule, 
which unbinds from the active site. The lysine substrate then binds to the pocket where it 
undergoes activation by the nearby glutamate residue and attacks the carbonyl of the 
acetylated cysteine. Collapse of the tetrahedral intermediate yields an acetylated lysine 
product, which then leaves the active site last.31 
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Figure I-5. MYST family acetyltransferase mechanism. 
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Conversely, the enzymes that remove the acetyl moiety from acetyllysine are 
dubbed histone deacetylases. Histone deacetylases are divided into four classes, where 
Class I, II, and IV HDACs are Zn2+-dependent enzymes and Class III HDACs (also 
called sirtuins) are NAD+-dependent. The sirtuin mechanism of action for the 
deacetylation of acetylated lysines will be reviewed in Chapter 2. For Class I, II, and IV 
HDACs, the zinc ion in the active site interacts with two aspartates, one histidine, and 
two nearby water molecules (Figure I-6).32, 33 Upon the entrance of acetyllysine, a 
nearby histidine residue activates one of the two water molecules bonded to the Zn2+ 
which then attacks the carbonyl group, forming a tetrahedral intermediate. Following the 
collapse of the tetrahedral intermediate, the acetyllysine is deacetylated and lysine is 
released.  
Another interesting structural feature of this mechanism is the presence of a 
conserved distal tyrosine residue that exhibits two distinct conformations termed out and 
in.33 In the absence of any acetyllysine substrate, the tyrosine residue adopts an outward-
facing formation, where no contacts with the active site are made. However, upon the 
entrance of acetyllysine into the active site, the enzyme adopts a conformation change, 
which then orients the tyrosine inward, creating a hydrogen bonding interaction with the 
oxygen of the acetyl moiety.  
In this dissertation, we study the site specificity of SIRT1 and SIRT2 on histone 
H3 acetylated nucleosomes. 
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Figure I-6. Catalytic mechanism for the deacetylation of acetyllysine by HDAC8. 
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Protein Lysine Crotonylation & Butyrylation 
 
Protein lysine crotonylation and butyrylation are two new acylations found on the 
histone protein. In 2007, a discovery by the Yingming Zhao group found two novel 
posttranslational modifications on histones: propionylation and butyrylation.34 Since its 
discovery, butyrylation has been found to be catalyzed by histone acetyltransferase p300. 
Another study by the Khochbin group found that histone H4K8bu is a transcriptionally 
activating marker. In addition, histone H4K8bu competes with acetylation at the same 
site in order to achieve the same overarching goal of gene transcription; however, the 
two compete posttranslational marks recruit different downstream binders.35 Later in 
2011, the Yingming Zhao group once again discovered another posttranslational 
modification on histones—crotonylation.36 This particular PTM was intriguing in that 
the mark seemed to propagate in gene promoter regions. Later studies demonstrated that 
crotonylation is associated with enhancers and active transcription start sites. Similar to 
butyrylation, histone acetyltransferases are able to catalyze the transfer of the crotonyl 
moiety from crotonyl-CoA onto histones.37 
 Theories on the regulation of crotonylation and butyrylation outside of enzymatic 
interactions suggest that intracellular concentrations of crotonyl-CoA and butyryl-CoA 
may be involved in the regulation of its specific PTM marker. A study conducted by the 
Sabari group, hypothesized that by downregulating acyl-CoA synthetase (ACSS2) in 
cells, there would be a decrease in the global concentration of histone crotonylation.37 
Their theory was found to be correct by the decrease in histone H3K18cr, suggesting that 
 16 
 
ACSS2 has a role in producing crotonyl-CoA in cells. In a follow up study, Sabari et al. 
found that the typical concentration of crotonyl-CoA in cells is generally lower than that 
of acetyl-CoA; however, by purposely downregulating the production of acetyl-CoA, the 
concentration of crotonyl-CoA increases.37, 38 This discovery suggested that acetyl-CoA 
and crotonyl-CoA might have competing roles in the modification of histone lysine sites. 
 However beyond these preliminary studies, much of crotonylation and 
butyrylation remains a mystery. Are butyryl-CoA and crotonyl-CoA possible substrates 
of histone acetyltransferases? What enzymes catalyze the decrotonylation and 
debutyrylation of the modified histone proteins? In this dissertation, we probe the 
deacylation ability of these two PTMs with SIRT1 and SIRT2 in vitro.  
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Histone Crosstalk 
As an effect of posttranslational modifications, histone proteins undergo a 
phenomenon called crosstalk—the activation or inhibition of a specific site’s 
modification as a direct result of another site’s modification. Histone crosstalk can occur 
in a manner of ways. Cross regulation in trans occurs when the modification target is not 
on the original histone substrate whereas in cis cross regulation occurs on the same 
histone (Figure I-7). Histone cross regulation can occur cross-nucleosome as well, 
modifying either contiguous nucleosomes or non-contiguous nucleosomes.  
An example of crosstalk is when histone H3S10 phosphorylation inhibits histone 
H3K9 acetylation and promotes histone H3K14 acetylation.39-41 Another type of 
crosstalk involves the promotion of one exclusive mark over another. Histone H3K9 can 
be either acetylated or methylated exclusively on a global level depending on the 
transcriptional state.42, 43 In other words, histone H3K9ac at one site can promote the 
acetylation of other nearby histone H3K9 sites to promote active transcription. 
Conversely, histone H3K9me can promote the methylation of other histone H3K9 sites 
to repress transcription.  
One final common example of histone crosstalk is the promotion of acetylation 
on the histone H4 N-terminal tail. Histone H4 has five critical lysine residues at histone 
H4K5, H4K8, H4K12, H4K16, and H4K20. Acetylation at any of these five sites will 
promote the acetylation of the other four, favoring an active transcriptional state.44  
Each of these modifications, both singular and combinatorial, closely regulate specific 
cellular functions within the cell. Additionally, certain crosstalk patterns can be 
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exclusive to one species. For example, in S. pombe, the acetylation of histone H3K14 
and methylation of histone H3K9 are antagonizing, whereas in human cells, histone 
H3K9me and H3K14ac can coexist on the same histone H3 tail.42, 45 
In a study probing the potential of histone acetyltransferase Gcn5 bromodomain-
mediated crosstalk, Shogren-Knaak and coworkers discovered that bromodomain 
recognition of histone H4K16ac promoted cooperative histone H3 acetylation at various 
sites.46, 47 By assembling arrays 12 nucleosomal units in length with acetylation at 
histone H4K16, their lab was able to demonstrate preferential acetylation by Gcn5 at 
histone H3K14ac, followed by acetylation at histone H3K9, H3K18, and H3K23. This 
analysis was the first in vitro crosstalk study.  
Previous crosstalk discoveries were observed in vivo, where the mechanism of crosstalk 
spanned across multiple enzymes in a complex; however, being able to isolate and 
simplify one of the many crosstalk models is the first step toward better understanding 
the individual pieces of histone crosstalk. Other histone-modifying enzymes, such as 
TIP60, SUV39H1, and SIRT1, are all involved in some form of crosstalk on the 
nucleosome, necessitating the need to better understand the individual enzymes as the 
first step toward fully understanding their involvement in histone crosstalk.48-52 In this 
dissertation, we choose to study the site and substrate specificity of SIRT1 and SIRT2. 
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Figure I-7. Histone crosstalk can occur in three ways: (A) in trans, (B) in cis, (C) and 
cross-nucleosome.  
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Synthetic Noncanonical Amino Acid Incorporation 
In order to study these histone proteins and their modifications, the need for a 
method of producing histones with defined posttranslational modifications is necessary. 
In the past, the most common practice for the study of histones was to extract the histone 
proteins from varying cell lines; however, because of the dynamic nature of 
posttranslational modifications in the cell, obtaining nucleosome or even histone protein 
with an isolated PTM or a specific combination of PTMs is difficult, if not impossible. 
As a solution, many scientists who wish to study the affect of specific PTMs in an in 
vitro environment looked to solid phase peptide synthesis (SPPS). SPPS is a convenient 
tool for the synthesis of peptides up to about 50 amino acids in length; however, since 
most native proteins with PTMs are over 50 amino acids, it is not an ideal solution.53 
Additionally, SPPS is a very expensive technique that is not available ubiquitously.  
 
Native Chemical Ligation 
The first major breakthrough and the most traditional method of incorporating 
noncanonical amino acids (ncAAs) was native chemical ligation (NCL), which involves 
the reaction between the N-terminal cysteine of one peptide with the C-terminal thioester 
of another. The reaction begins with the thiol group on the cysteine exchanging with the 
thiol group on the thioester. The reaction creates a new thioester linkage which then 
undergoes an intramolecular rearrangement to produce the final combined peptide 
(Figure I-8).54 Since the reaction involves the conjugation of two peptides synthesized 
by solid phase peptide synthesis, this method allows for the synthesis of proteins up to 
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100 amino acids in length. However, there are two major limitations: (1) SPPS is an 
expensive and tedious technique with low yield and (2) the desired protein will have a 
cysteine residue in its peptide sequence. In native chemical ligation, following the 
synthesis of desired peptide, the reaction is commonly never 100% efficient, meaning 
that the product itself must be further purified by column chromatography, most likely 
high performance liquid chromatography (HPLC), which further decreases the already 
low yield of the peptide. In most cases this limitation of yield can be sidestepped by 
scaling down the assay conditions; however, in nucleosome reconstitution, a large 
amount of protein/peptide is needed for the successful refolding, which makes 
nucleosome study highly unlikely with NCL. Additionally, since one of the precursor 
peptides must have a cysteine residue for native chemical ligation to proceed, the 
product will have a native cysteine in its protein sequence. This case is not ideal when 
the protein of interest does not have a cysteine in its native protein sequence, making this 
technique highly protein selective.  
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Figure 1-8. Native chemical ligation. 
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Expressed Protein Ligation 
The next step in the chemical synthesis of posttranslationally modified proteins 
came with the development of expressed protein ligation (EPL).55 EPL uses a technique 
termed protein splicing, which is a technique that involves an intramolecular 
rearrangement to remove an internal sequence and join two remaining sequences via the 
same chemistry as NCL to produce a protein amide bond.56, 57 By using recombinant 
protein technology, a protein sequence of choice is fused to intein on the C-terminal 
followed by an affinity-binding domain, most commonly chitin-binding domain. A 
peptide with an N-terminal cysteine is then synthesized using SPPS. The protein is then 
bound to a column via its corresponding affinity tag and treated with another thiol 
bearing nucleophile, which then allows the protein with the C-terminal thioester to react 
with the N-terminal cysteine peptide and form the desired product (Figure I-9). This 
new method removes the 100 amino acid limitation since bacterially expressed proteins 
are not limited to 50 amino acids. In addition, the cost of such expressed proteins is 
much lower than SPPS with the added benefit of higher yields. However, many of the 
limitations of native chemical ligation remain with expressed protein ligation—protein 
selectivity, possible mutated protein sequence, and the need for extra purification.  
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Figure I-9. Expressed protein ligation. 
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Synthetic Preparation of Histones 
Recently, a method popularized by the Ottesen lab for the synthetic preparation 
of histone H3 with posttranslational modifications employs a modified NCL approach, 
but uses three peptide fragments instead of two.58 Histone H3 has various acetylation 
sites in its 134 amino acid sequence that cannot be synthesized using regular EPL and 
NCL techniques, such as histone H3K56 and H3K79. In this method, in addition to the 
synthesis of a C-terminal thioester (Fragment 1) and an N-terminal cysteine peptide 
(Fragment 2), an additional peptide with both a protected N-terminal cysteine and C-
terminal thioester (Fragment 3) is synthesized. Fragments 2 and 3 are then ligated 
together using conventional NCL chemistry. Following completion, the thiazolidine is 
deprotected to generate a free terminal cysteine, which is then reacted with Fragment 1 
to yield full-length histone H3. Although this approach allows for the study of 
previously unattainable sites on histone H3, this approach does not solve the previous 
limitations of NCL—cost and yield—but merely exacerbates the situation; however, this 
is the only current way to synthesize full-length histone proteins with modifications in 
the middle of the proteins. 
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Genetic Noncanonical Amino Acid Incorporation 
With the increasing interest in studying posttranslational modifications, a new 
method for incorporating noncanonical amino acids into proteins using a genetic 
approach was developed by Peter Schultz and coworkers. The technique was inspired by 
the discovery of the 21st and 22nd amino acids, selenocysteine and pyrrolysine, 
respectively.59, 60 Selenocysteine and pyrrolysine were both particularly fascinating 
discoveries in that they employed stop codons for their incorporation into proteins—
UGA and UAG, respectively.61, 62 Whereas the normal 20 amino acids have multiple 
codon recognition combinations, both selenocysteine and pyrrolysine have only one 
codon recognition site. This is significant in that neither of these two amino acids 
compete with another amino acid for incorporation. With its aminoacyl-tRNA synthetase 
and cognate tRNA, the tRNA is charged with the amino acid at the cost of one ATP 
molecule. The anticodon region of the tRNA then binds to the codon corresponding to 
the amino acid on the mRNA strand, following which the amino acid is then added onto 
the growing protein chain (Figure I-10). Schultz and coworkers use this genetic 
machinery as a model to introduce an orthogonal tRNA/aaRS into cells, meaning the 
pair only work together and cannot compete with other tRNA/aaRS pairs.63, 64 Schultz 
and coworkers eventually developed a system employing a 𝑡𝑅𝑁𝐴𝐶𝑈𝐴
𝑇𝑦𝑟
/tyrosyl-tRNA 
synthetase pair from the archaea M. jannaschii expressed in bacterial E. coli.64 
Following suit, the Liu group has taken full advantage of the 𝑡𝑅𝑁𝐴𝐶𝑈𝐴
𝑃𝑦𝑙
/pyrrolysyl-tRNA 
synthetase pair for the expression of multiple phenylalanine and lysine derivatives.65-71  
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The genetic noncanonical amino acid (ncAA) approach has strengths where 
previous synthetic ncAA incorporation failed. Bacterial expression is more cost efficient 
and available to any research group with an interest in chemical biology. In addition, 
since the proteins are recombinantly expressed, the protein yields are multiple times 
larger. The need for multiple purification steps is also generally negated with the 
introduction of affinity tags, such as HisTag, GST Tag, etc.72-74 Even the ability to 
express proteins with two different ncAAs has been achieved in the past, albeit with low 
yield.75 With the rising demand in studying posttranslational modifications relating to 
the nucleosome, the need for a method in which histone protein can be expressed quickly 
and efficiently is needed. The genetic noncanonical amino acid approach provides such a 
way to meet this demand and is thus used as the primary method of expression for all 
histone proteins in this dissertation. 
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Figure I-10. Genetic ncAA incorporation machinery using a pyrrolysine model. 
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CHAPTER II  
SIRTUIN 
 
     Introduction 
 Sirtuins are Class III histone deacetylases that require NAD+ as a co-substrate for 
the catalytic removal of the acetyl moiety from acetyllysine. The first sirtuin enzyme, 
yeast Sir2, was first discovered in 1979 and was described as a protein required in the 
silencing of HM loci.76 Later that year three more proteins were discovered with similar 
functions and the name silent information regulator (Sir) proteins were assigned to this 
new group of proteins.77 It wasn’t until 1999 when Kaeberlein and coworkers reported 
that overexpression of Sir2 had the ability to extend the lifespan of yeast by up to 70%.78 
From this discovery, a significant rise in interest in sirtuins was created.  
 Later studies found seven enzymes in mammalian cells with strong similarities to 
yeast Sir2 and termed SIRT1-7.77 Localization of these sirtuins varies within the cell. 
Sirtuin 1, 2, and 6 are mainly nuclear enzymes, although SIRT2 is able to shuttle 
between the cytoplasm and nucleus depending on the cell state. Sirtuin 3-5 are mainly 
mitochondrial enzymes. Sirtuin 7 is localized in the nucleus as well; however, the 
enzyme is most commonly found in the nucleolus. The sirtuin family of enzymes have 
gained much interest in the past couple decades for their ability to not only catalyze the 
deacetylation of acetyllysine, but also for their ability to act as regulators of health and 
metabolism.79-84 Most interestingly, most sirtuins have been confirmed to have the 
ability to perform a variety of deacylations beyond acetylation, such as crotonylation, 
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butyrylation, octanoylation, and myristoylation (Figure II-1b).13 Given the large scope 
of substrates these mammalian sirtuins can target, the need for more research become 
more significant in order to fully understand the role and function of sirtuins specifically 
within the cell. In this dissertation, SIRT1 and SIRT2 reactivity on several acylation sites 
will be described in detail. 
 
 
 
 
 
 
Figure II-1. A) Crystal structure of SIRT2 bound to acetyllysine. PDB: 3PDH B) Five 
sirtuin substrates. 
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Mechanism 
 
 Structural studies of SIRT2 have shown when the substrate protein and NAD+ 
are bound in their respective binding pockets, the oxygen on the acetyl group attacks the 
nicotinamide at the C1’ position of the ribose ring. The nicotinamide structure is then 
ejected from the catalytic pocket and an alpha-1’-O-alkylamidate intermediate is formed. 
A nearby histidine residue then activates the 2’-OH group on the ribose ring, which 
attacks the carbonyl of the intermediate and forms a bicyclic intermediate. Hydrolysis of 
this intermediate releases the deacetylated lysine as well as one O-acetyl ADP ribose 
group (Figure II-2). A high cellular concentration of nicotinamide has been shown to 
inhibit this mechanism at the formation of the alkylamidate intermediate.85, 86 
 The collapse of the bicyclic intermediate has long been a point of contention. A 
study by the Zhang lab has shown that a critical water molecule located in a water 
channel close to the cofactor binding loop forms a hydrogen bond with the 1’ oxygen 
atom of the intermediate.87 Their mechanism proposed based on ab initio quantum 
mechanics/molecular mechanics (QM/MM) simulations is as follows: First, the bond 
between the C and O1’ is broken, which is stabilized through interactions with the 
nearby water molecule. Next, nucleophilic attack by water creates a tetrahedral 
intermediate, which eventually collapses to yield one free lysine and O-acetyl ADP 
ribose group (Figure II-3). A point of interest in this mechanism is that the positioning 
of the water molecule must be shielded prior to its role in the collapse of the bicyclic 
intermediate. Otherwise, hydrolysis of the O-alkylamidate intermediate would yield a 
hydrolyzed ADP ribose product. This shielding effect is achieved through a patch of 
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hydrophobic residues. As the deacetylation mechanism proceeds, the sirtuin enzyme 
slightly shifts the positioning of this hydrophobic cluster in order to allow or deny access 
to the cofactor-binding site based on which intermediate is currently present. In addition, 
this particular structural feature is highly conserved throughout the sirtuin family, 
implying that the enzymatic design of this mechanism is deliberate.87, 88 
 
 
 
 
 
 
Figure II-2. Sirtuin deacetylation mechanism. 
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Figure II-3. Proposed mechanism for the collapse of the bicyclic intermediate. 
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SIRT1 and SIRT2 as Histone Deacylases  
 At the time of discovery, SIRT1 and SIRT 2 were found to deacetylate histone 
H3K9ac, H3K14ac, and H4K16ac in vivo, similar to its yeast Sir2 counterpart. These 
modifications listed are confirmed gene activating marks on chromatin by promoting the 
change from euchromatin to heterochromatin with the help of binding proteins.88-91 
Beyond these initial studies, continued studies of sirtuin enzymes on the nucleosome and 
even the histone protein ceased due to lack of accessible experimental methods to 
synthesize or express homogenously posttranslationally modified histone proteins. 
Preliminary efforts incubated acetylated histone peptides generated by solid phase 
peptide synthesis with SIRT1 and SIRT2 in vitro; however, the deacetylation rates of 
their acetylated peptides were very low, raising questions as to whether or not they were 
actual deacetylation targets.91, 92 Studies have confirmed histone H3K9ac and H4K16ac 
as SIRT1 and SIRT2 deacetylation sites, and histone H3K14ac as another with slower 
activity, but a large majority of the histone sites remained non-targets.89, 93  
 In order to better understand the role of SIRT1 and SIRT2 in vivo, Oberdoerffer 
and coworkers discovered in a study that SIRT1- and SIRT2-deficient mice have an 
increase in DNA damage, which caused downstream irregularities leading to various 
cancers.94 In addition, Reinberg and coworkers managed to develop a knockdown SIRT1 
cell line, which was characteristic of hyperacetylated levels of histone H3K9 and 
H4K16, regular SIRT1 targets. Conversely, overexpression of SIRT1 led to the 
deacetylation of histone H3K9ac and H4K16ac, leading to the eventual downstream 
pause of gene expression.91 Another study by Dryden et al. found that SIRT2 has the 
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ability to control the mitotic exit in the cell cycle. Downregulation of SIRT2 in this study 
demonstrated a majority of cells being shut down at the G2/M phase of mitosis.95 Other 
studies have found that sirtuin has the ability to regulate lifespan in a diet-dependent 
manner related to calorie restriction and suppress tumorigenesis by regulating APC/C 
activity.96 However, details of how SIRT1 and SIRT2 were able to perform these actions 
on the chemical level were still not understood.  
 Through the efforts of the Liu group, it was found that SIRT1 and SIRT2 target a 
wide variety of histone H3 sites with acetyllysine, crotonyllysine, or butyryllysine 
installed (Figure II-4 & II-5).97 SIRT1 and SIRT2, which were long known to 
demonstrate tight substrate specificities on peptide substrates, showed almost no 
substrate specificity on the nucleosome or tetramer level. This discovery was significant 
in that the implications of an enzyme with a wide substrate scope in both site specificity 
as well as PTM-type specificity helped bridge the understanding between SIRT1 and 
SIRT2’s role in regulating cellular health in the cell. It was concluded that SIRT1 and 
SIRT2 have the ability to regulate and police the presence of specific posttranslational 
modifications at specific moments in the cell cycle, as a defender of cellular health and 
longevity.  
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Figure II-4. Deacetylation profile of SIRT1 and SIRT2 on the nucleosome. PDB: 1KX5 
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Figure II-5. Decrotonylation and debutyrylation profile of SIRT1 and SIRT2 on the 
histone H3/H4 tetramer. PDB: 1KX5 
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SIRT1 and SIRT2 in Transcriptional Roles 
 
 Another critical function of SIRT1 and SIRT2 is in its involvement in DNA 
damage and repair.88, 98 Usually under moments of oxidative stress in the cell, SIRT1 
plays a major role in DNA damage maintenance by recruiting and activating repair 
proteins. A study by Wang et al. demonstrated that in mice with the SIRT1 gene 
knocked out, there was an increase in the number of damaged DNA sites on chromatin 
as well as a noticeable failure in the DNA repair machinery.98 This study concluded that 
SIRT1 did in fact play critical roles in the process of DNA repair. Another study 
demonstrated SIRT1’s ability in inhibiting the apoptotic-favored Ku70-BAX 
disassociation machinery.99, 100 In response to DNA damage, Ku70 is normally 
acetylated at multiple sites, breaking its interaction with BAX, also known as bcl-2-like 
protein 4. BAX then translocates to the mitochondria where it induces cellular apoptosis. 
However, in the presence of SIRT1, the acetylation sites of Ku70 are removed, 
maintaining the interaction between Ku70 and BAX, preventing apoptosis and 
promoting Ku70-mediated DNA damage repair.99 
 SIRT2 demonstrates a similar role in DNA maintenance, but through other 
means. As mentioned earlier, SIRT2 is most commonly localized in the cytoplasm; 
however, during cell division, SIRT2 translocates into the nucleus to act as a manager in 
cell division, regulating several key steps in mitosis.93, 96, 101 To begin, SIRT2 has the 
ability to regulate anaphase by promoting APC/C (anaphase-promoting complex) 
activity. At the beginning of metaphase, APC/C is inhibited; however, by deacetylating 
the co-activators of APC/C, APC/C is activated, allowing for the complex to mark 
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proteins for degradation and push the mitotic cycle from metaphase into anaphase.96 
SIRT2 has also been demonstrated to act as a regulator of the G2/M phase. During this 
phase, SIRT2 functions as a key regulator in chromatin compaction by deacetylating 
histone H4K16ac and promoting the monomethylation of H4K20. A study done in 
SIRT2-deficient mice demonstrated an inability to methylate histone H4K20, which 
resulted in cellular cessation of mitosis at the G2/M phase. In addition, the same study 
demonstrated that the same SIRT2-deficient mice exhibited characteristic signs pointing 
to tumorigenesis.102 
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CHAPTER III 
DEVELOPMENT OF AN ELISA-BASED RAPID THROUGHPUT ASSAY FOR THE 
ENZYMATIC PROFILING OF SIRT1 AND SIRT2 ON TEN MONO-ACETYLATED 
HISTONE H3 NUCLEOSOMES* 
 
Introduction 
 Lysine acetylation on nucleosomal histones serve as prominent epigenetic marks 
for gene regulation, which are installed by histone acetyltransferases and removed by 
histone deacetylases (HDACs).103 There are four classes of HDACs. Unlike traditional 
classes I, II, and IV HDACs that are Zn2+-dependent, class III HDAC enzymes are 
NAD+-dependent called sirtuins.104 Sirtuin 1 (SIRT1) and Sirtuin 2 (SIRT2) are two 
sirtuin enzymes that can translocate between the nucleus and the cytoplasm.105 Recent 
studies indicate that these two enzymes regulate necessary cellular processes such as 
metabolism, cellular health, as well as genomic stability.106-111 Indeed, SIRT2-deficient 
mice have demonstrated an increase in DNA damage, which acts as the preliminary 
force for the development of various cancers.96, 102, 112 This is characteristic of SIRT1-/- 
mice as well.94, 98 
 
 
___________________ 
*Reprinted in part with permission from “Sirtuins 1 and 2 are Universal Deacetylases.” by W. W. 
Hsu, B. Wu, W. R. Liu, ACS Chemical Biology, (2016), 11, 792-799. Copyright © 2016 American 
Chemical Society 
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 Of their regulatory duties, a prominent function of SIRT1 and SIRT2 is their role 
in gene silencing and DNA repair, which is achieved via the deacetylation of acetylated 
histone lysine residues.113 Previous in vitro studies have reported deacetylation of 
acetylated histone H3 lysine 9 (H3K9ac), H3K14ac, and H4K16ac by SIRT1 and histone 
H3K9ac by SIRT2, which are confirmed gene activating post-translational marks on 
histones.88, 93, 113, 114 However, beyond the initial studies, limited efforts have been made 
to completely understand the overall character of these two enzymes on the nucleosome. 
Past studies have perceived SIRT1 and SIRT2 to demonstrate substrate selectivity; 
however, their spacious substrate-binding sites seem to suggest otherwise.91, 92, 114 In 
addition, most of the previous in vitro studies have used histone N-terminal tail peptide 
substrates that may not properly represent their native nucleosomal counterparts.13, 91, 92 
Using peptides as substrates discounts the information related to the contribution of the 
nucleosome core and other histone tails involved in the enzymatic deacetylation process. 
Unlike the acetyllysine sites on the histone N-terminal tails that may rearrange in a 
variety of orientations to interact with SIRT1 and SIRT2, the acetyllysine sites near or in 
the nucleosome core region such as K36, K56, K79, and K115 of histone H3 have more 
stringent conformational environments and lack the flexibility of peptides when 
interacting with SIRT1 and SIRT2. In this regard, using peptides as substrates can lead 
to potentially misleading results. We aim to resolve these issues related to the current 
activity studies of SIRT1 and SIRT2 using homologous nucleosome substrates that are 
site-specifically installed with acetyllysine.  
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 In this work, we implement an integrated method combining our ability to 
incorporate noncanonical amino acids with an ELISA-based rapid throughput assay 
approach to survey which lysine sites on histone H3 can be targeted by SIRT1 and 
SIRT2. Our experimental set up allows for up to sixteen concurrent time-dependent 
enzymatic assays at once, which permits for the expedient profiling of enzymatic 
substrate specificity on the nucleosome. In this manner, we were able to characterize the 
ability of SIRT1 and SIRT2 to deacetylate nucleosomes with mono-acetylated histone 
H3 over a four-hour time course. In this study, we report that SIRT1 and SIRT2 display 
relatively little substrate specificity across various histone H3 acetyllysine sites on the 
nucleosome. In addition, both SIRT1 and SIRT2 display heightened enzymatic activity 
when incubated with a nucleosome substrate versus its peptide counterpart. This 
discovery potentially indicates that the nucleosome core and other histone tails have 
roles in contributing to the binding of and the subsequent deacetylation by SIRT1 and 
SIRT2.  
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Experimental Details 
Construction of Plasmids 
 In order to express the various histone proteins for nucleosome assembly, four 
separate plasmids were constructed using an empty pETDuet-1 plasmid as the backbone: 
pETDuet-H2A, pETDuet-H2B, pETDuet-H3, and pETDuet-SUMO-TEV-H4. The 
histone DNA fragments were amplified out of their respective plasmids and ligated into 
the second MCS of an empty pETDuet vector. A forward primer was specially designed 
to include the DNA sequence for a HisTag-TEV linker. In this way, each histone 
sequence was preceded by a HisTag-TEV linkage at the N-terminus. BL21(DE3) cells 
were transformed to hold the expression vectors.  
 pETDuet-SUMO-TEV-H4 was designed after the pETDuet-H4 construct 
demonstrated poor yield over multiple expression cultures. The cloning procedure was 
similar to the construction of the other three histone plasmids. First, two new restriction 
sites were introduced between the HisTag DNA sequence using QuikChange 
mutagenesis. SUMO was then cloned into the new region using a forward primer 
containing the DNA sequence for HisTag. In this manner, a DNA sequence culminating 
in His-tagged SUMO-TEV-H4 was designed where after TEV cleavage, the native 
histone H4 protein could be obtained. 
 
Construction of Histone H3 Mutant Plasmids 
 The aforementioned human histone H3 gene was cloned into a pETDuet-1 
plasmid. In following, a site-specific amber mutation was made to the wild-type gene by 
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Quikchange mutagenesis in order to obtain the desired mutagenic feature (H3K4TAG, 
H3K9TAG, etc.) BL21(DE3) cells were transformed with the histone H3 mutant and its 
respective pEVOL construct for expression. 
 
Histone H2A, H2B, H3 Expression and Purification 
 N-terminal His-tagged wild-type H2A, H2B, and H3 were grown in 2×YT media 
to OD600 0.40–0.60 and then supplemented with 0.800 mM IPTG to induce expression 
for 4 hours at 37oC. Cells were then collected by centrifugation at 4 K for 20 minutes. 
Following resuspension with a lysis buffer containing 20 mM Tris-HCl (pH 7.5), 500 
mM NaCl, 0.1% NaN3, and 0.1% Triton X-100, the cells were lysed by sonication at 
4oC. For a general 1 L expression, 40 mL of lysis buffer was used for resuspension. The 
cell lysate was then centrifuged at 6 K for 20 minutes and the pellet was collected. The 
pellet was then resuspended in a lysis wash buffer containing 20 mM Tris-HCl (pH 7.5), 
500 mM NaCl, and 0.1% NaN3 and centrifuged at 6 K for 20 minutes. This process was 
repeated another time under the same conditions. The resulting pellet was then collected 
an dissolved in a urea buffer containing 20 mM Tris-HCl (pH 7.5), 500 mM NaCl, and 6 
M urea and incubated at 37oC for 1 hour. The solution was then cleared by 
centrifugation at 10 K for 40 minutes. 
 The supernatant was then collected and subjected to a Ni SepharoseTM 6 Fast 
Flow column (GE Healthcare). The column was washed with a wash buffer containing 
20 mM Tris-HCl (pH 7.5), 500 mM NaCl, 20 mM imidazole, and 6 M urea for at least 
10 column volumes. After the column was washed adequately, the protein was eluted 
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with a second buffer containing 20 mM Tris-HCl (pH 7.5), 500 mM NaCl, 300 mM 
imidazole, and 6 M urea. Following purification, the proteins were then dialyzed to a 
temporary storage buffer containing 20 mM Tris-HCl (7.5), 500 mM NaCl, and 6 M urea 
two times at 4oC. The protein absorbance at Abs280 was then obtained and the 
concentration was calculated using a known extinction coefficient. For long-term 
storage, the proteins were then dialyzed into water four times at 4oC, lyophilized and 
stored at -80oC. 
 Generally, the yields of wild-type histone H2A and H2B were around 10-15 
mg/L while histone H3 had a yield of around 25 mg/L. The purity of these three proteins 
is shown in Figure III-1. 
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Figure III-1. 15% SDS Page gel depicting the wild-type expression of His-tagged 
histone H2A, H2B, and H3. 
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Histone H3 Mutant Expression and Purification 
 Mutant histones were grown in 200 mL 2×YT until OD600 0.4-.0.6 and then 
supplemented with 0.800 mM IPTG, 5mM nicotinamide, 0.02% arabinose, and 2 mM 
noncanonical amino acid at 37oC for 12 hours. The subsequent steps follow the same 
procedure as their wild-type counterparts. Purified proteins were lyophilized and stored 
at -80oC. 
 The general yield of the histone mutants varied greatly between 2 – 10 mg/L 
depending on the compatibility of the noncanonical amino acid with the PylRS mutant 
used. 
 
SUMO-TEV-H4 Expression 
 His-tagged SUMO-TEV-H4 was grown in 1L 2×YT until OD600 0.4-0.6 and then 
supplemented with 0.800 mM IPTG at 37oC for 2 hours. The subsequent steps are 
identical overall to the purification of the other wild-type histones with the following 
differences: (1) Cells were lysed by sonication under gentler conditions at 4oC, and (2) 
SUMO-TEV-H4 was washed on the Ni SepharoseTM 6 Fast Flow column (GE 
Healthcare) for 15 column volumes. The purified protein was then quantified and stored 
at -80oC. 
 The yield of His-tagged SUMO-TEV-H4 was around 10 mg/L. The purity of 
SUMO-TEV-H4 is shown in Figure III-2. 
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Figure III-2. 15% SDS Page gel depicting the purification of His-tagged SUMO-TEV-
H4. 
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TEV Protease Expression and Purification 
 N-terminal His-tagged TEV protease was grown in 500 mL 2×YT media to 
OD600 0.40–0.60 and then supplemented with 0.800 mM IPTG to induce expression for 
4 hours at 37oC. Cells were then collected by centrifugation at 4 K for 20 minutes. 
Following resuspension with 30 mL of a lysis buffer containing 10 mM Na3PO4 (pH 
8.0), 150 mM NaCl, 5 mM KCl, and 0.1% Tween 20, the cells were lysed by sonication 
at 4oC. The cell lysate was then centrifuged at 10 K for 40 minutes. 
 The supernatant was then collected and applied to a Ni SepharoseTM 6 Fast Flow 
column (GE Healthcare) at 4oC. The column was washed with a chilled wash buffer 
containing 50 mM Na3PO4 (pH 8.0), 200 mM NaCl, 20 mM imidazole, and 10% 
glycerol for 10 column volumes. After wash, the enzyme was eluted with a chilled 
buffer containing 50 mM Na3PO4 (pH 8.0), 200 mM NaCl, 300 mM imidazole, and 10% 
glycerol. The enzyme was then dialyzed into a storage buffer containing 20 mM Tris 
(pH 7.5), 500 mM NaCl, and 5 mM 2-mercaptoethanol at 4oC. Following dialysis, the 
protein concentration of the enzyme was determined using UV-Vis and then distributed 
into 5 μm aliquots and stored at -80oC until the time of use. 
 
SIRT1 and SIRT2 Expression 
 HisTagged SIRT1 and SIRT2 were expressed using 2000 mL of 2YT media 
supplemented with 0.8 mM IPTG for 16 hours at 16oC. The cells were induced between 
OD600 0.4-0.6. Cells were harvested and lysed by sonication in lysis buffer 20 mM Tris-
HCl (pH 7.5), 200 mM NaCl, 0.1mM phenylmethylsulfonyl fluoride, 0.1% Tween-20. 
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Following centrifugation, the supernatant was incubated with nickel-nitrilotriacetic acid 
resin for 1 hour at 4oC. The resin was then loaded onto a column and rinsed with 100 mL 
wash buffer 20 mM Tris-HCl (pH 7.5), 200 mM NaCl, 20 mM imidazole, 5 mM 2-
mercaptoethanol. Following wash, the protein was eluted with 20 mM Tris-HCl (pH 
7.5), 200 mM NaCl, 300 mM imidazole, 5 mM 2-mercaptoethanol, concentrated, and 
loaded onto a Q Sepharose Fast Flow column (GE Healthcare). Fractions containing the 
enzyme were then collected, concentrated, and loaded onto a Superdex 200 10/300 GL 
column (GE Healthcare) for further purification (Figure III-3 & III-4). The final purified 
protein was dialyzed in 20 mM Tris-HCl (pH 7.5), 200 mM NaCl, 5 mM 2-
mercaptoethanol and stored at -80oC in 10% glycerol at a final concentration of 5 µM. 
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Figure III-3. SIRT1 purification on the Superdex 200 10/300 GL column. 
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Figure III-4. SIRT1 purification on the Superdex 200 10/300 GL column. 
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Octamer Refolding 
 Histone octamers were assembled in the following manner. Recombinantly 
expressed HisTag-TEV-H2A, HisTag-TEV-H2B, HisTag-TEV-H3 (or HisTag-TEV-
acetyl-H3), and HisTag-SUMO-TEV-H4 were dissolved in a histone unfolding buffer 
containing 20 mM Tris-HCl (pH 7.5), 500 mM NaCl, and 6 M urea in equimolar ratios. 
The mixture was dialyzed using Slide-A-Lyzer MINI Dialysis devices (3,500-Da cutoff) 
obtained from ThermoFisher Scientific at 4oC against 4x 500 mL octamer refolding 
buffer containing 20 mM Tris-HCl (pH 7.5) and 500 mM NaCl for 4 hours total. The 
concentration of octamer during refolding was 2.5 mg/mL. Following the completion of 
refolding, octamers were transferred to microcentrifuge tubes and spun down at 14,000 
rpm for 1 minute to remove any precipitate. Following confirmation of octamer 
formation with SDS-PAGE, the histone octamer was incubated with TEV protease for 
24 hours at 4oC. The TEV protease treated octamer sample was administered to a Ni-
NTA column to remove the digested HisTag, SUMO protein, the undigested octamer, 
and TEV protease. The remaining octamer was stored at 4oC on ice for short-term and –
20oC for long-term storage. Typical octamer yields ranged between 60–80% (Figure III-
5). 
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Figure III-5. Successful octamer refolding from two separate occasions. 
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P601 DNA Preparation 
 P601 DNA was prepared using a forward primer (5’-CTG GAG AAT CCC GGT 
GCC G-3’) and a primer (5’-GAC AGG ATG TAT ATA TCT GAC ACG TGC C-3’) 
from Integrated DNA Technologies to amplify the 147bp fragment P601 in the plasmid 
pGEM-3z-601 (Addgene) using PCR. For biotinylated-P601 DNA, a biotinylated 
reverse primer was used instead (biotin-5’-GAC AGG ATG TAT ATA TCT GAC ACG 
TGC C-3’). The PCR product was concentrated to 25 µM using general DNA 
concentration protocols and then used for subsequent nucleosome reconstitutions (Figure 
III-6). 
  
 56 
 
 
 
 
 
 
 
Figure III-6. PCR amplified P601 DNA fragment used for nucleosome reconstitution on 
1% agarose EtBr gel. 
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Nucleosome Reconstitution 
 In a general reconstitution process, 2.8 µg (25 pmol) octamer was refolded with 
2.2 µg DNA (25 pmol) using rapid salt gradient dilution starting from an initial salt 
concentration of 2 M NaCl to a final concentration of 250 mM NaCl in 30 minute time 
intervals with 10mM Tris (pH 7.5) buffer. Intermediate NaCl concentrations were 1.5 M, 
1 M, 500 mM, and 250 mM. Reconstituted nucleosomes were stored at 4oC on ice for 
short-term storage until used. Nucleosomes were analyzed using 6% polyacrylamide-
TBE native gels. Successful nucleosome reconstitutions were characterized by a band 
present between 400-500 bp DNA marker. Typical yields ranged between 60–100% 
(Figure III-7). 
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Figure III-7. 6% polyacrylamide-TBE native gel of various successful nucleosome 
reconstitutions. Nucleosome formation characterized by the appearance of a band 
between 400 - 500 bp. 
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Nucleosome Deacetylation Assays 
 Acetyl-nucleosome was bound to a streptavidin-coated 96-well plate with a 
buffer containing 20 mM Tris (pH 7.5) and 250 mM NaCl.  5 μM SIRT1 or SIRT2 
(100nM final concentration) and 1 mM NAD+ were added into wells to initiate the 
deacetylation process. In addition, wild-type nucleosome was provided in an adjacent 
well to serve as a negative control. The well in which no sirtuin enzyme was provided 
over the course of the assay (the 0 hour time point) was used as a positive control. 
Reactions were stopped at different time intervals by decanting solution and washing 
with a buffer with 20 mM Tris (pH 7.5) and 250 mM NaCl. Following the completion of 
the assay, the plate was blocked with milk for one hour, washed three times with PBST, 
and then incubated with pan anti-acetyllysine antibody for one hour. The plate was then 
washed five times with PBST with agitation for at least two minutes between each wash 
step. Subsequently the second antibody was applied to each well for one hour. Following 
the same wash procedure, the acetylation levels were detected using SuperSignal ELISA 
Pico Chemiluminescent Substrate from Thermo Fisher Scientific with a BioTek Synergy 
H1 microplate reader. The following results were then collected and processed using 
appropriate software. 
 
Peptide Deacetylation Assays  
 Biotinylated acetyl-H3 peptides were analyzed in the same manner as in the 
nucleosome deacetylation assay. 
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Solution Phase Deacetylation Assays 
 Acetyl-H3 tetramers were incubated with 5 μM of their respective sirtuin enzyme 
for four hours at room temperature in a buffer with 20mM Tris (pH 7.5) and 250mM 
NaCl. The reactions were quenched and the conventional western blot procedure was 
carried out for analysis. 
 
Gene Sequences 
HisTag and Cleavage Site DNA Sequence 
CATCACCATCATCACCACAGCCAGGATCCGGAAAATCTGTACTTCCAG 
 
Histone H2A DNA Sequence 
TCTGGTCGTGGTAAACAAGGTGGTAAAGCACGTGCAAAGGCTAAGACTCGT
AGCAGCCGTGCCGGTCTGCAGTTTCCAGTGGGTCGCGTTCACCGTCTGCTGC
GTAAAGGCAACTATGCTGAACGTGTGGGTGCTGGTGCACCGGTTTACCTGGC
AGCTGTACTGGAATATCTGACCGCAGAGATTCTGGAGCTGGCAGGTAACGC
AGCTCGTGATAATAAGAAGACCCGCATCATCCCACGTCACCTGCAGCTGGCC
ATCCGCAACGATGAGGAACTGAACAAACTGCTGGGCAAAGTTACTATCGCT
CAAGGTGGCGTTCTGCCGAACATCCAGGCAGTTCTGCTGCCGAAGAAAACC
GAATCCCACCACAAAGCGAAAGGTAAGTGA 
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Histone H2B DNA Sequence 
TCAGAACCAGCTAAGTCTGCACCGGCTCCGAAGAAAGGCTCTAAGAAGGCT
GTTACCAAGGCTCAGAAGAAAGATGGTAAGAAACGCAAACGTTCTCGTAAA
GAAAGCTATTCTGTGTACGTGTATAAAGTTCTGAAACAAGTACATCCAGACA
CTGGCATTTCCAGCAAAGCGATGGGCATTATGAACAGCTTCGTTAACGATAT
CTTCGAACGTATCGCAGGCGAAGCGAGCCGTCTGGCTCACTATAACAAACGT
TCTACCATCACCTCTCGTGAAATTCAAACTGCAGTTCGTCTGCTGCTGCCAGG
TGAACTGGCTAAACACGCGGTTAGCGAAGGCACTAAAGCAGTTACCAAATA
CACTTCTTCCAAATGA 
 
Histone H3 DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTAAGTCCACTGGCGGTAAAGCGCCGCGT
AAACAGCTGGCAACCAAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGC
GTGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCC
GCCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACG
TCTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCT
AGCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGT
TCGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCC
GAAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
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Histone H4 DNA Sequence 
TCTGGTCGTGGTAAAGGTGGTAAAGGCCTGGGTAAAGGTGGTGCTAAGCGT
CACCGTAAAGTGCTGCGCGACAACATCCAGGGTATCACCAAACCAGCTATTC
GCCGTCTGGCACGTCGCGGTGGTGTGAAACGCATCAGCGGTCTGATCTATGA
AGAAACCCGTGGTGTTCTGAAAGTATTTCTGGAGAACGTTATCCGCGATGCG
GTGACCTACACCGAACACGCGAAACGTAAGACCGTTACTGCTATGGATGTTG
TGTACGCTCTGAAACGCCAGGGTCGTACTCTGTACGGTTTCGGTGGCTGA 
 
HisTag-SUMO DNA Sequence 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCG
GCAGCCATATGTCGGACTCAGAAGTCAATCAAGAAGCTAAGCCAGAGGTCA
AGCCAGAAGTCAAGCCTGAGACTCACATCAATTTAAAGGTGTCCGATGGATC
TTCAGAGATCTTCTTCAAGATCAAAAAGACCACTCCTTTAAGAAGGCTGATG
GAAGCGTTCGCTAAAAGACAGGGTAAGGAAATGGACTCCTTAAGATTCTTGT
ACGACGGTATTAGAATTCAAGCTGATCAGACCCCTGAAGATTTGGACATGGA
GGATAACGATATTATTGAGGCTCACAGAGAACAGATTGGTGGT 
Histone H3K4TAG DNA Sequence 
GCTCGCACCTAGCAGACTGCTCGTAAGTCCACTGGCGGTAAAGCGCCGCGTA
AACAGCTGGCAACCAAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGCG
TGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCCG
CCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACGT
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CTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCTA
GCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGTT
CGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCCG
AAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
 
Histone H3K9TAG DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTTAGTCCACTGGCGGTAAAGCGCCGCGTA
AACAGCTGGCAACCAAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGCG
TGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCCG
CCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACGT
CTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCTA
GCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGTT
CGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCCG
AAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
 
Histone H3K14TAG DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTAAGTCCACTGGCGGTTAGGCGCCGCGTA
AACAGCTGGCAACCAAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGCG
TGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCCG
CCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACGT
CTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCTA
GCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGTT
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CGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCCG
AAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
 
Histone H3K18TAG DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTAAGTCCACTGGCGGTAAAGCGCCGCGTT
AGCAGCTGGCAACCAAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGCG
TGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCCG
CCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACGT
CTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCTA
GCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGTT
CGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCCG
AAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
 
Histone H3K23TAG DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTAAGTCCACTGGCGGTAAAGCGCCGCGT
AAACAGCTGGCAACCTAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGC
GTGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCC
GCCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACG
TCTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCT
AGCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGT
TCGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCC
GAAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
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Histone H3K27TAG DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTAAGTCCACTGGCGGTAAAGCGCCGCGT
AAACAGCTGGCAACCAAGGCAGCGCGTTAGAGCGCTCCAGCTACTGGCGGC
GTGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCC
GCCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACG
TCTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCT
AGCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGT
TCGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCC
GAAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
 
Histone H3K36TAG DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTAAGTCCACTGGCGGTAAAGCGCCGCGT
AAACAGCTGGCAACCAAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGC
GTGTAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCC
GCCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACG
TCTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCT
AGCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGT
TCGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCC
GAAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
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Histone H3K56TAG DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTAAGTCCACTGGCGGTAAAGCGCCGCGT
AAACAGCTGGCAACCAAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGC
GTGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCC
GCCGCTACCAGTAGAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACG
TCTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCT
AGCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGT
TCGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCC
GAAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
 
Histone H3K79TAG DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTAAGTCCACTGGCGGTAAAGCGCCGCGT
AAACAGCTGGCAACCAAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGC
GTGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCC
GCCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACG
TCTGGTTCGCGAAATTGCTCAGGATTTCTAGACCGACCTGCGCTTCCAGTCTA
GCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGTT
CGAAGATACCAACCTGTGCGCAATCCATGCAAAGCGTGTAACCATTATGCCG
AAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
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Histone H3K115TAG DNA Sequence 
GCTCGCACCAAACAGACTGCTCGTAAGTCCACTGGCGGTAAAGCGCCGCGT
AAACAGCTGGCAACCAAGGCAGCGCGTAAAAGCGCTCCAGCTACTGGCGGC
GTGAAGAAGCCGCACCGTTATCGCCCGGGTACTGTGGCTCTGCGTGAAATCC
GCCGCTACCAGAAAAGCACCGAACTGCTGATTCGCAAACTGCCATTTCAACG
TCTGGTTCGCGAAATTGCTCAGGATTTCAAAACCGACCTGCGCTTCCAGTCT
AGCGCTGTGATGGCACTGCAAGAGGCGTCTGAGGCATATCTGGTTGGCCTGT
TCGAAGATACCAACCTGTGCGCAATCCATGCATAGCGTGTAACCATTATGCC
GAAAGACATCCAACTGGCTCGTCGTATCCGTGGTGAGCGTGCGTGA 
 
P601 DNA Sequence 
CTGGAGAATCCCGGTGCCGAGGCCGCTCAATTGGTCGTAGACAGCTCTAGCA
CCGCTTAAACGCACGTACGCGCTGTCCCCCGCGTTTTAACCGCCAAGGGGAT
TACTCCCTAGTCTCCAGGCACGTGTCAGATATATACATCCTGT 
 
MmAcKRS DNA Sequence 
ATGGATAAAAAACCACTAAACACTCTGATATCTGCAACCGGGCTCTGGATGT 
CCAGGACCGGAACAATTCATAAAATAAAACACCACGAAGTCTCTCGAAGCA 
AAATCTATATTGAAATGGCATGCGGAGACCACCTTGTTGTAAACAACTCCAG 
GAGCAGCAGGACTGCAAGAGCGCTCAGGCACCACAAATACAGGAAGACCTG 
CAAACGCTGCAGGGTTTCGGATGAGGATCTCAATAAGTTCCTCACAAAGGCA 
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AACGAAGACCAGACAAGCGTAAAAGTCAAGGTCGTTTCTGCCCCTACCAGA 
ACGAAAAAGGCAATGCCAAAATCCGTTGCGAGAGCCCCGAAACCTCTTGAG 
AATACAGAAGCGGCACAGGCTCAACCTTCTGGATCTAAATTTTCACCTGCGA 
TACCGGTTTCCACCCAAGAGTCAGTTTCTGTCCCGGCATCTGTTTCAACATCA 
ATATCAAGCATTTCTACAGGAGCAACTGCATCCGCACTGGTAAAAGGGAAT 
ACGAATCCCATTACATCCATGTCTGCCCCTGTTCAGGCAAGTGCCCCCGCAC 
TTACGAAGAGCCAGACTGACAGGCTTGAAGTCCTGTTAAACCCAAAAGATG 
AGATTTCCCTGAATTCCGGCAAGCCTTTCAGGGAGCTTGAGTCCGAATTGCT 
CTCTCGCAGAAAAAAAGACCTGCAGCAGATCTACGCGGAAGAAAGGGAGAA 
TTATCTGGGGAAACTCGAGCGTGAAATTACCAGGTTCTTTGTGGACAGGGGT 
TTTCTGGAAATAAAATCCCCGATCCTGATCCCTCTTGAGTATATCGAAAGGA 
TGGGCATTGATAATGATACCGAACTTTCAAAACAGATCTTCAGGGTTGACAA 
GAACTTCTGCCTGAGACCCATGATGGCTCCAAACCTGCTGAACTACGCCCGC 
AAGCTTGACAGGGCCCTGCCTGATCCAATAAAAATTTTTGAAATAGGCCCAT 
GCTACAGAAAAGAGTCCGACGGCAAAGAACACCTCGAAGAGTTTACCATGC 
TGAACTTCTGCCAGATGGGATCGGGATGTACACGGGAAAATCTTGAAAGCA 
TAATTACGGACTTCCTGAACCACCTGGGAATTGATTTCAAGATCGTAGGCGA 
TTCCTTCATGGTCTTGGGGGATACCCTTGATGTAATGCACGGAGACCTGGAA 
CTTTCCTCTGCAGTAGTCGGACCCATACCGCTTGACCGGGAATGGGGTATTG 
ATAAACCCTGGATAGGGGCAGGTTTCGGGCTCGAACGCCTTCTAAAGGTTAA 
ACACGACTTTAAAAATATCAAGAGAGCTGCAAGGTCCGAGTCTTACTATAAC 
GGGATTTCTACCAACCTGTAA 
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Protein Sequences 
HisTag and Cleavage Site 
GSSHHHHHHSQDPENLYFQ 
 
Histone H2A  
SGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYAERVGAGAPVYLA
AVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGV
LPNIQAVLLPKKTESHHKAKGK 
 
Histone H2B  
SEPAKSAPAPKKGSKKAVTKAQKKDGKKRKRSRKESYSVYVYKVLKQVHPDT
GISSKAMGIMNSFVNDIFERIAGEASRLAHYNKRSTITSREIQTAVRLLLPGELAK
HAVSEGTKAVTKYTSSK 
 
Histone H3  
ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
 
Histone H4  
SGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEET
RGVLKVFLENVIRDAVTYTEHAKRKTVTAMDVVYALKRQGRTLYGFGG 
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HisTag-SUMO  
MGSSHHHHHHSSGLVPRGSHMSDSEVNQEAKPEVKPEVKPETHINLKVSDGSSE
IFFKIKKTTPLRRLMEAFAKRQGKEMDSLRFLYDGIRIQADQTPEDLDMEDNDII
EAHREQIGG 
 
Histone H3K4 Mutant  
ARTXQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
 
Histone H3K9 Mutant  
ARTKQTARXSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
 
Histone H3K14 Mutant  
ARTKQTARKSTGGXAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
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Histone H3K18 Mutant  
ARTKQTARKSTGGKAPRXQLATKAARKSAPATGGVKKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
 
Histone H3K23 Mutant  
ARTKQTARKSTGGKAPRKQLATXAARKSAPATGGVKKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
 
Histone H3K27 Mutant  
ARTKQTARKSTGGKAPRKQLATKAARXSAPATGGVKKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
 
Histone H3K36 Mutant  
ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVXKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
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Histone H3K56 Mutant  
ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRR
YQXSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
 
Histone H3K79 Mutant  
ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFXTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAKRVTIMPKDIQLARRIRGERA 
 
Histone H3K115 Mutant  
ARTKQTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGTVALREIRR
YQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTN
LAAIHAXRVTIMPKDIQLARRIRGERA 
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Results and Discussion 
Design of Experiments for the Rapid Examination of SIRT1 and SIRT2 Activities 
 The basis of our approach is to utilize DNA-labeled nucleosomes—in our case, 
biotin-conjugated DNA—on an appropriate affinity-labeled 96-well plate for the rapid 
and efficient time-dependent screening of any enzyme (Figure III-8A). Our technique 
combines the ease and familiarity of western blot for detection and the efficiency of a 
rapid, streamlined nucleosome screening approach that is achieved when using 96-well 
plates. Furthermore, by placing the affinity tag on DNA rather than the nucleosome, we 
minimize the physical interference between the plate and enzyme during the screening 
process. Our aim during the method’s development was to establish a straightforward 
and convenient technique that allows for rapid in vitro enzymatic profiling. As a 
demonstration of our technique, we report the deacetylase ability of SIRT1 and SIRT2 
on multiple mono-acetylated histone H3 nucleosomes in a time-dependent manner. 
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Figure III-8. An ELISA system for site recognition assays of sirtuin enzymes. (A) 
Peptides or nucleosomes with acetyllysine (Kac) were immobilized on the bottom of a 
96-well plate. The deacetylation assay was then carried out with a sirtuin enzyme. After 
the reaction completed, they were probed by a pan anti-acetyllysine antibody followed 
by a horseradish peroxidase (HRP)-conjugated secondary antibody. A chemiluminescent 
substrate was then provided and the signals were detected in a microplate reader. (B) 
Acetyl-nucleosomes were assembled by refolding equimolar amounts of histone H2A, 
H2B, H3, and H4 with 147bp P601 DNA. Nucleosome formation was determined using 
a gel shift assay. (C) 6%-TBE native gel of the ten unique acetyl-nucleosomes refolded 
in this study. 
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Expression of Acetyl-H3 Proteins and Reassembly of Acetyl-Nucleosomes  
 In order to profile lysine recognition sites of SIRT1 and SIRT2, histone H3 
proteins with mono-acetylation at sites including K4, K9, K14, K18, K23, K27, K36, 
K56, K79, and K115 were expressed and refolded into nucleosomes together with 
biotin-conjugated P601 DNA and recombinant H2A, H2B, and H4 proteins (Figure III-
8B–C). The expression of the acetylated histone H3 (acetyl-H3) proteins in E. coli was 
achieved by using a mutant acetyllysine-specific pyrrolysyl-tRNA synthetase together 
with its cognate 𝑡𝑅𝑁𝐴𝐶𝑈𝐴
𝑃𝑦𝑙
. 
 
SIRT1 and SIRT2 Have Higher Activities on Nucleosomes than Peptides  
 As an initial study to demonstrate the viability of our method, we compared the 
enzymatic activities of both SIRT1 and SIRT2 on two separate substrate architectures—
the peptide and the nucleosome. A notable increase was seen in the enzymatic activity 
for both sirtuin enzymes when incubated with a nucleosome assembled from histone 
H3K9ac (nucleosome-H3K9ac) against its acetylated peptide (peptide-H3K9ac) 
counterpart with SIRT1 and SIRT2 (Figure III-9). The rise in activity may be attributed 
to the possibility of stabilizing, secondary binding interactions that are achievable with 
the nucleosome substrate but not with the peptide, such as interactions with the N-tail or 
core region of another histone protein in the octamer. Therefore, acetyl-nucleosomes 
serve as more efficient and reliable substrates for both SIRT1 and SIRT2 over their 
peptide counterparts. For this reason, in the following experiments, only acetyl-
nucleosomes were utilized for the assays of SIRT1 and SIRT2.  
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Figure III-9. Comparative study of SIRT1 and SIRT2 activity on acetyl-peptides and 
nucleosomes. (A) SIRT1 activity on peptides and nucleosomes containing an 
acetyllysine at histone H3K9 and H3K79. (B) SIRT2 activity on peptides and 
nucleosomes containing an acetyllysine at histone H3K9 and H3K79. Peptides and 
nucleosomes were immobilized by biotin on streptavidin plates. 
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SIRT1 Demonstrates Relatively No Selectivity on the Histone H3 N-terminal Tail  
 SIRT1 demonstrates relatively little substrate specificity amongst the pool of 
nucleosomes assembled from ten mono-acetylated histone H3 proteins (Figure III-10). 
Two exceptions in this study were histone H3K27ac and H3K56ac. We reason that due 
to the spacious nature of the SIRT1 active site, enzymatic deacetylation may be more 
dependent on the positioning of the acetyllysine toward the active site than the 
neighboring interactions between the adjacent residues on the substrate and the active 
site environment.115  
 When considering the catalytic residues involved in sirtuin-related deacetylation, 
most catalytically critical residues interact with the NAD+ molecule rather than the 
substrate. The main documented interactions maintained between the sirtuin and 
acetylated substrate are through backbone interactions and surface contacts from 
residues four to five units away from the target modification rather than direct side-chain 
interactions in the active site; however, more distant residues may also influence 
deacetylation through other sirtuin interactions or through conformation-inducing 
interactions.115, 116 Rauh et al. recently determined the specificity of SIRT1 across a wide 
acetylome peptide library.92 In this study, they reported that SIRT1 displays some 
preferentiality with the neighboring residues surrounding the site of acetylation. SIRT1 
exhibits a preference for mainly positively charged residues surrounding the acetylation 
site as well as non-charged residues at positions +2, +3, and –2, with a slight disfavoring 
for negatively charged residues surrounding the modification site. These features 
seemingly accommodate the binding groove of SIRT1 at which the peptides in the 
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microarray bound, which has a negatively charged bottom. One concern from the study; 
however, was that there is no guarantee that the native substrates would behave the same 
as their peptide counterparts due to the possibility of other auxiliary binding interactions 
unattainable through peptide studies. When applying the pattern determined by Rauh et 
al. to our acetylated nucleosome substrates, inconsistencies with SIRT1-targeted histone 
H3 lysine sites on the nucleosome profiled in the current study were observed. The 
surrounding sequences of the SIRT1-targeted histone H3 lysine sites demonstrated no 
convergence. Since the nucleosome is a robust and large complex, we reason that there 
must exist other stabilizing features that help overcome these perceived mismatches. In 
fact when considering the discoveries reported on acetylated histone H3 peptide studies, 
SIRT1 only demonstrates deacetylation reportedly at histone H3K9ac and to a lesser 
extent on H3K14ac.92 However, based on the findings we report, SIRT1 demonstrates a 
wide range of deacetylase ability across the entirety of the histone H3 protein on the 
nucleosome. 
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Figure III-10. The deacetylation activity of SIRT1 on ten acetyl-nucleosomes. (A) The 
activity of SIRT1 on ten selected histone H3 lysine sites. (B) The sequence of histone 
H3. The N-terminal tail region is displayed in black and the core region in blue. 
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 When considering the criteria the enzyme must meet to initiate deacetylation, 
SIRT1 has two requirements: (1) the co-factor and substrate must both be bound and (2) 
the enzyme must enter its closed state.115 In regards to these two requirements, it is 
plausible that the positioning of the acetyllysine is primarily mediated by the 
nucleosome complex, independent of its localization on the protein, meaning the 
adjacent histones—histone H2A, H2B, and H4—may interact with the sirtuin in a way 
as to aid the enzymatic reaction. Once positioned toward the active site, the SIRT1 
enzyme can begin to exit its apo form and begin the deacetylation process. 
 As previous literature has reported, SIRT1 demonstrates the ability to deacetylate 
histone H3K9ac and H3K14ac, with a slightly higher preference for the former over the 
latter.91, 114 Along with the remaining six sites that were deacetylated in our assay—
histone H3K4ac, H3K18ac, H3K23ac, H3K36ac, H3K79ac, H3K115ac—, there was no 
significant outlier in relative enzymatic activity suggesting that SIRT1 activity is not 
predominantly determined by the adjacent amino acid sequence near the acetyllysine site 
but rather by some other undetermined enzyme-substrate binding factor.  
 Although nucleosome-H3K56ac was not deacetylated in our assay, several 
studies have reported its deacetylation in vivo.117 We believe that since histone H3K56ac 
closely interacts with the nucleosomal DNA, the circumstance under which histone 
H3K56ac can be deacetylated may be dependent on the binding of other enzymes for 
stability or the loosening of DNA (or DNA damage) in the area near H3K56ac, features 
unattainable in our in vitro assay.118  
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 In addition to nucleosome-H3K56ac, histone H3K27ac displayed no detectable 
deacetylation on the nucleosome. When considering the amino acid sequence near the 
site of acetylation, the region was mainly occupied by serine and alanine and an arginine 
directly adjacent to the modification site, residues with favorable binding interactions as 
described by Rauh et al.92 In addition to the nucleosome study, we performed the 
deacetylation assay on the H3-H4 tetramer in the case that the DNA may have 
interrupted the deacetylation assay in some manner, which is discussed in further detail 
below. We hypothesize that similar to nucleosome-H3K56ac, nucleosome-H3K27ac has 
been made inaccessible to the sirtuin enzyme in some manner. From these studies, we 
conclude that SIRT1 does not recognize histone H3K27ac as a deacetylation target on 
the nucleosome in vitro; however, the ability of H3K27ac to be deacetylated in vivo, 
where the molecular system extends beyond simple nucleosome-sirtuin binding, remains 
to be seen. 
 
SIRT2 Demonstrates Relatively No Selectivity on the Histone H3 N-terminal Tail 
 Akin to SIRT1, mammalian SIRT2 demonstrates essentially no substrate 
preferentiality on the ten acetyl-nucleosomes (Figure III-11). One exception in this assay 
was nucleosome-H3K56ac where previous in vivo data demonstrated deacetylation at 
this site by SIRT2.117 This event may be similar to that of SIRT1 where SIRT2 requires 
other binding partners to aid in the deacetylation of this particular acetyllysine site due to 
its close interaction with the nucleosomal DNA. This would be achieved by either 
slightly unraveling the DNA or by binding to the DNA and thereby stabilizing the 
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docking of SIRT2 onto the nucleosome, or a combination of both events occurring. 
Alternatively, SIRT2 may interact with the H3-H4 tetramer—a native substrate in vivo 
that is absent of DNA—for the catalytic removal of acetylation at histone H3K56ac.
 Since SIRT1 and SIRT2 belong in the same HDAC class, many of the details 
reported previously are relevant here as well. As reported with the SIRT1 catalytic site, 
most of the major SIRT2 catalytic contacts are with the bound NAD+ molecule, leaving 
only basic backbone electrostatic interactions with the substrate.115, 116 Though the 
catalytic core of SIRT1 and SIRT2 share a strong sequence identity, the catalytic pockets 
are not identical.115, 116 The same peptide acetylome microarray discussed earlier with 
SIRT1 also analyzed SIRT2.92 In this microarray, SIRT2 demonstrates a preference for a 
positively charged residue at the +4 position from the acetyllysine. In addition, the 
SIRT2 active site strongly disfavors negatively charged residues in the proximity of the 
modification site, which coincides with the active site’s polar peptide-binding cleft and 
negatively charged bottom. In the same case as SIRT1; however, the sequence data 
appear to influence very little of the enzyme’s specificity on the nucleosome. Previous 
studies on SIRT2 have only reported the enzyme’s ability to deacetylate histone H3K9ac 
and H3K56ac.91, 117 In this study, we have demonstrated that SIRT2 has the ability to 
deacetylate nine different histone H3 acetyl-nucleosomes. One exception to our study 
was the deacetylation of nucleosome-H3K56ac, which was addressed previously. 
  
 83 
 
 
 
 
 
 
 
Figure III-11. The deacetylation activity of SIRT2 on ten acetyl-nucleosomes. 
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 Like SIRT1, the catalytic core of SIRT2 can be categorized in two forms: open 
and closed.116 In the apo state, SIRT2 exposes its hydrophobic core as well as the NAD+- 
and substrate-binding sites. When both substrate and co-factor bind, the enzyme then 
enters its closed state.115, 116, 119 From our SIRT2 deacetylation assay, no particular site 
where deacetylation was observed on the nucleosome architecture demonstrated a higher 
preferentiality over any other, suggesting that the presence of the nucleosome complex 
contributes a stabilizing force in SIRT2 activity. 
 
SIRT1 Demonstrates the Ability to Deacetylate Tetramer-H3K27ac 
 As a follow up to our previous suppositions, we incubated tetramer-H3K27ac 
with SIRT1 in the solution phase to demonstrate the ability of the enzyme to remove the 
deacetylation mark in the absence of nucleosomal DNA. Indeed, SIRT1 does 
demonstrate the ability to deacetylate tetramer-H3K27ac (Figure III-12A). This finding 
upholds our previous assumption that SIRT1 can recognize histone H3K27ac; however, 
based on our nucleosome-H3K27ac and tetramer-H3K27ac data, the site itself does not 
appear to be a SIRT1 favored deacetylation site in vitro.  
  
 85 
 
 
 
 
 
 
 
Figure III-12. Solution-based deacetylation assays of tetramer-H3K27ac with SIRT1 
and tetramer-H3K56ac with SIRT1 and SIRT2. Experimental conditions were identical 
to the microplate-based assay. (A) Solution-based SIRT1 activity on tetramer-H3K27ac. 
(B) Solution-based SIRT1 and SIRT2 activity on tetramer-H356ac. 
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SIRT1 and SIRT2 Demonstrate the Ability to Deacetylate Tetramer-H3K56ac in the 
Solution Phase 
 In addition, we probed the ability of SIRT1 and SIRT2 to remove tetramer-
H3K56ac (Figure III-12B). Both sirtuin enzymes demonstrated an apt ability to readily 
deacetylate the tetrameric protein in solution. We conclude in this study that the DNA in 
nucleosome-H3K56ac interferes with SIRT1 and SIRT2 binding; however, in the 
absence of the nucleosomal DNA, histone H3K56ac is readily removed by the two 
sirtuin enzymes. 
  
 87 
 
Conclusion and Outlook 
From the data presented in this study, we have demonstrated that both SIRT1 and 
SIRT2 show relatively little substrate specificity in vitro; however, several in vivo 
studies have presented evidence that suggests SIRT1 and SIRT2 have a higher 
preference for certain lysine sites over others.91, 93 We believe that the substrate 
specificity of SIRT1 and SIRT2 in vivo may be dependent on their binding partners and 
the cellular context in which they are needed. For instance, following DNA replication 
the acetylation level at H3K56 rises when DNA damage accumulates during the 
replication process.117, 120 In response, SIRT2 is co-localized in the regions of high 
histone H3K56ac levels with other DNA damage markers, such as p53, pATM, and 
CHK2, in order to repair the DNA damage.118 Previous data have demonstrated a 
dependence on initial SIRT1-binding at regions of genomic instability for the 
recruitment of other enzymes. Dobbin et al. found that during the maintenance of 
genomic stability in neurons, HDAC1 recruitment to the DNA damage site cannot occur 
without SIRT1 preliminarily binding.121 Other instances include the deacetylation of 
histone H3K9ac and H3K14ac as transcriptional repressing markers by SIRT1.114 The 
deacetylation of histone H3K18ac by SIRT2 is seemingly situational as well, reported to 
function under the context of Listeria monocytogenes infection.122 We believe our 
findings suggest a similar biological context in the examples above. Though SIRT1 and 
SIRT2 demonstrate the ability to remove acetylation from multiple sites along the 
histone H3 structure, the cellular context in which each deacetylation may occur remains 
to be discovered. Nevertheless, the implication of the two sirtuin enzymes and their non-
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specificity implies a more flexible enzyme, able to respond to various cellular situations 
within the cell, rather than an enzyme specially designed for one singular task or 
function. 
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CHAPTER IV 
ENZYMATIC PROFILING OF SIRT1 AND SIRT2 ON NINE CROTONYLATED 
AND BUTYRYLATED HISTONE H3 TETRAMERS 
 
Introduction 
 Histone posttranslational modifications (PTMs) play a vital role in myriad 
cellular functions, such as gene transcription and repression, cellular health, chromatin 
compaction and decompaction, DNA repair, and more.108, 109, 123-126 Crotonylation and 
butyrylation are newly discovered PTMs found on histones that potentially function as 
active gene promoters similar to their acetyl counterpart.34, 36 A few studies conducted 
have discovered that histone acetyltransferases p300 and CBP can catalyze lysine 
butyrylation.34, 36, 37, 127 In addition, histone deacetylase SIRT1-3 has been found to 
regulate histone H3K4cr levels in vivo, as well as decrotonylate histone H3K4cr peptides 
in vitro.128 Despite the surging progress in the discovery of new histone acylations, there 
still exists a stunning lack of systematic studies done to elucidate how these new 
acylations interact with existing histone modifying enzymes.  
 Sirtuins are NAD+-dependent histone deacetylases that have the ability to control 
gene expression. SIRT1 and SIRT2 are two of the seven enzymes in the sirtuin family 
localized in the nucleus.128 A previous study conducted by the Liu lab has demonstrated 
that SIRT1 and SIRT2 display almost no substrate specificity across ten histone H3 
lysine sites. We concluded in this study that SIRT1 and SIRT2 are flexible enzymes with 
the ability to respond to various cellular situations.97 Since the discovery that 
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crotonyllysine can be a viable substrate for sirtuins, we sought to elucidate the role of 
SIRT1 and SIRT2 on other short-chain acyllysines.128 
 Here we implement our developed genetic noncanonical amino acid (ncAA) 
approach to express crotonylated and butyrylated histone H3 for the purpose of 
systematically studying the site and substrate specificity of SIRT1 and SIRT2 on the 
histone tetramer in vitro. From our study, we discovered that the two sirtuins 
demonstrate very little substrate specificity across the most of the histone H3 lysine 
sites. These findings support our previous supposition that SIRT1 and SIRT2 are 
enzymes of an adaptive nature with their specificity likely being tied to their binding 
partners. 
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Experimental Details 
Cloning of Histone H3 Mutants 
 The human histone H3 gene was cloned into a pETDuet-1 plasmid. Site-specific 
amber mutations were made to the wild-type gene via Quikchange mutagenesis to obtain 
the desired mutagenetic feature (H3K4TAG, H3K9TAG, etc.) This process was repeated 
until all nine plasmids containing the desired histone H3 mutation were developed. 
 
Expression and Purification of HisTag-SUMO-TEV-H4 
 A fusion gene coding an N-terminal His-tagged SUMO-linked to histone H4 with 
a TEV protease cleavage sit between them was cloned into a pETDuet-1 plasmid. The 
plasmid was then used to transform E. coli BL21 (DE3) cells. The transformed cells 
were then grown in 2×YT media to OD600 0.4–0.6 and supplemented with 1 mM IPTG 
to induce expression for 4 hours at 37oC. Cells were then collect by centrifugation and 
resuspended in lysis buffer containing 20 mM Tris-HCl (pH 7.5), 500 mM NaCl, 0.1% 
NaN3, and 0.1% Triton X-100. Cells were then lysed by sonication at 4
oC on ice. The 
cell lysate was then centrifuged and the pellet was obtained, which was then dissolved in 
a lysis wash buffer containing 20 mM Tris-HCl (pH 7.5), 500 mM NaCl, and 0.1% 
NaN3. The cells were spun down twice by centrifugation in the lysis wash buffer. 
Following the second wash, the cell pellet was then dissolved in a urea buffer containing 
20 mM Tris-HCl (pH 7.5), 500 mM NaCl, and 6 M urea and cleared by centrifugation. 
The supernatant was then collected and applied to a Ni SepharoseTM 6 Fast Flow column 
(GE Healthcare). The column was washed with a wash buffer containing 20 mM Tris-
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HCl (pH 7.5), 500 mM NaCl, 20 mM imidazole, and 6 M urea. The protein was eluted 
with an elution buffer containing 20 mM Tris-HCl (pH 7.5), 500 mM NaCl, 300 m M 
imidazole, and 6 M urea. Following purification, the proteins were lyophilized and 
stored at -80oC. 
 
Expression and Purification of Crotonyl- and Butyryl-H3 Proteins 
 To express crotonylated or butyrylated histone H3 proteins, pEVOL-MmBuKRS 
and a pETduet-1-based plasmid coding histone H3 with an amber mutation were used to 
transform E. coli BL21 (DE3) cells. Cells were grown in 2×YT media to OD600 0.4–0.6 
and the expression of the acylated histone H3 proteins were induced with an additional 1 
mM crotonyllysine or butyryllysine, 5 mM nicotinamide, 0.2% arabinose and 1 mM 
IPTG for 12 hours at 37oC. The subsequent purification was identical to the purification 
steps above. The purity of the proteins was visualized by SDS-PAGE (Figure IV-1). 
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Figure IV-1. Expression of histone H3K4cr and H3K4bu. 
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Histone H3/H4 Tetramer Refolding 
 Histone H3/H4 tetramers were assembled in the following manner. 
Recombinantly expressed HisTag-TEV-crotonyl-H3 (or HisTag-TEV-butyryl-H3) and 
HisTag-SUMO-TEV-H4 were dissolved in a histone unfolding buffer containing 20 mM 
Tris-HCl (pH 7.5), 500 mM NaCl, and 6 M guanidinium chloride in equimolar ratios. 
The mixture was dialyzed using Slide-A-Lyzer MINI Dialysis devices (3,500-Da cutoff) 
obtained from Fisher Scientific at 4oC against 4x 500 mL tetramer refolding buffer 
containing 20 mM Tris-HCl (pH 7.5) and 500 mM NaCl for 2 hours total. The 
concentration of the tetramer during refolding was carefully adjusted to 2.0 mg/mL to 
avoid protein aggregation. After refolding, histone H3/H4 tetramers were transferred to 
microcentrifuge tubes and centrifuged at 14,000 rpm for 10 min to remove any 
precipitate. Following confirmation of tetramer formation with SDS-PAGE, tetramers 
were stored at 4oC until use (Figure IV-2B). 
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Figure IV-2. SDS-PAGE gel of A) histone H2A/H2B dimer and B) histone H3/H4 
tetramer. 
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Expression and Purification of SIRT1 and SIRT2 
 N-terminal His-tagged SIRT1 and SIRT2 were expressed in 2000 mL of 2×YT 
media with 1 mM IPTG at OD600 0.4-0.6 for 16 hr at 16
oC. Cells were harvested at 4000 
rpm for 20 min and subsequently lysed by sonication in a lysis buffer containing 20 mM 
Tris-HCl (pH 7.5), 200 mM NaCl, 0.1 mM phenylmethylsulfonyl fluoride, and 0.1% 
Tween-20. Following centrifugation, the supernatant was incubated with Ni-NTA 
(nickel-nitrilotriacetic acid) resin for 30 min at 4oC. The resin was then washed with 50 
mL wash buffer 20 mM Tris-HCl (pH 7.5), 200 mM NaCl, 20 mM imidazole, 5 mM 2-
mercaptoethanol. The protein was then eluted with an elution buffer containing 20 mM 
Tris-HCl (pH 7.5), 200 mM NaCl, 300 mM imidazole, 5 mM 2-mercaptoethanol. The 
imidazole was then dialyzed out, and the sample was applied to a Q Sepharose Fast Flow 
column (GE Healthcare). The fractions containing the enzyme were collected and loaded 
onto a Superdex 200 10/300 GL column (GE Healthcare) for further purification. The 
final protein was dialyzed to a storage buffer containing 20 mM Tris-HCl (pH 7.5), 200 
mM NaCl, 5 mM 2-mercaptoethanol and stored at -80oC in 20% glycerol at a 
concentration of 5 𝜇M. 
 
Tetramer Deacylation Assay 
 Crotonylated or butyrylated tetramers were incubated with 5 μM SIRT1 or 
SIRT2 and 1 mM NAD+ in a buffer containing 20 mM Tris (pH 7.5) and 500 mM NaCl 
for 2hr at 37oC. Reactions were then quenched with 5mM nicotinamide and run on SDS-
PAGE. Conventional western blot procedure was carried out for analysis using the 
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appropriate pan anti-acyllysine antibody (PTM Biolabs). An anti-H3 antibody was used 
as an internal control (Cell Signaling Technology). 
 
Gene Sequences 
 Gene sequences for histone H3 (and its mutants), H4, HisTag, and HisTag-
SUMO are available in Chapter III. 
 
MmBuKRS DNA Sequence 
ATGGATAAAAAACCACTAAACACTCTGATATCTGCAACCGGGCTCTGGATGT 
CCAGGACCGGAACAATTCATAAAATAAAACACCACGAAGTCTCTCGAAGCA 
AAATCTATATTGAAATGGCATGCGGAGACCACCTTGTTGTAAACAACTCCAG 
GAGCAGCAGGACTGCAAGAGCGCTCAGGCACCACAAATACAGGAAGACCTG 
CAAACGCTGCAGGGTTTCGGATGAGGATCTCAATAAGTTCCTCACAAAGGCA 
AACGAAGACCAGACAAGCGTAAAAGTCAAGGTCGTTTCTGCCCCTACCAGA 
ACGAAAAAGGCAATGCCAAAATCCGTTGCGAGAGCCCCGAAACCTCTTGAG 
AATACAGAAGCGGCACAGGCTCAACCTTCTGGATCTAAATTTTCACCTGCGA 
TACCGGTTTCCACCCAAGAGTCAGTTTCTGTCCCGGCATCTGTTTCAACATCA 
ATATCAAGCATTTCTACAGGAGCAACTGCATCCGCACTGGTAAAAGGGAAT 
ACGAACCCCATTACATCCATGTCTGCCCCTGTTCAGGCAAGTGCCCCCGCAC 
TTACGAAGAGCCAGACTGACAGGCTTGAAGTCCTGTTAAACCCAAAAGATG 
AGATTTCCCTGAATTCCGGCAAGCCTTTCAGGGAGCTTGAGTCCGAATTGCT 
CTCTCGCAGAAAAAAAGACCTGCAGCAGATCTACGCGGAAGAAAGGGAGAA 
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TTATCTGGGGAAACTCGAGCGTGAAATTACCAGGTTCTTTGTGGACAGGGGT 
TTTCTGGAAATAAAATCCCCGATCCTGATCCCTCTTGAGTATATCGAAAGGA 
TGGGCATTGATAATGATACCGAACTTTCAAAACAGATCTTCAGGGTTGACAA 
GAACTTCTGCCTGAGACCCATGCTTGCTCCAAACCTTTACAACTACCTGCGC 
AAGCTTGACAGGGCCCTGCCTGATCCAATAAAAATTTTTGAAATAGGCCCAT 
GCTACAGAAAAGAGTCCGACGGCAAAGAACACCTCGAAGAGTTTACCATGC 
TGAACTTCTGCCAGATGGGATCGGGATGCACACGGGAAAATCTTGAAAGCA 
TAATTACGGACTTCCTGAACCACCTGGGAATTGATTTCAAGATCGTAGGCGA 
TTCCTGCATGGTCTGGGGGGATACCCTTGATGTAATGCACGGAGACCTGGAA 
CTTTCCTCTGCAGTAGTCGGACCCATACCGCTTGACCGGGAATGGGGTATTG 
ATAAACCCTGGATAGGGGCAGGTTTCGGGCTCGAACGCCTTCTAAAGGTTAA 
ACACGACTTTAAAAATATCAAGAGAGCTGCAAGGTCCGAGTCTTACTATAAC 
GGGATTTCTACCAACCTGTAA 
 
Protein Sequence 
 Protein sequences for histone H3 (and its mutants), H4, HisTag, and HisTag-
SUMO are available in Chapter III. 
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Scheme IV-1. Synthesis of Nε-butyryl and Nε-crotonyl-L-lysine hydrochloride. 
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 Synthesis of Nε-butyryl and Nε-crotonyl-L-lysine Hydrochloride 
Synthesis of Boc-Lys(Z)-OMe (2) 
 To a suspension of Boc-Lys(Z)-OH (1, 40.3 g, 0.106 mol) and potassium 
carbonate (27.6 g, 0.200 mol) in DMF (200 mL) iodomethane (9.90 mL, 0.159 mol) was 
added, and the mixture was stirred at room temperature for 30 h. The mixture was 
filtered, and the filter cake was washed with ethyl acetate (50 mL), dissolved in water 
(100 mL), and extracted with ethyl acetate (100 mL) two times. The ethyl acetate 
solutions were combined with the filtrate, and the solution was evaporated under vacuum 
until most of the DMF had been removed. The residue was redissolved in ether (250 
mL), washed with water (100 mL) and brine (50 mL), dried (Na2SO4), and evaporated to 
afford 2 (41.8 g, quant.) as a yellow oil. The material was pure enough for the next-step 
reaction without further treatment. 
 
Synthesis of Nα-Boc-Nε-butyryl-L-lysine Methyl Ester (3)  
 A solution of 2 (4.20 g, 10.6 mmol) in methanol (100 mL) was hydrogenated 
under a H2 balloon in the presence of palladium on carbon (10 wt.% Pd, 0.71 g, 0.67 
mmol) at room temperature for 3 h, and TLC analysis showed a complete conversion. 
The mixture was then filtered over a pad of Celite and the solution was directly used for 
the next step reaction. The material was immediately used without purification since 
prolonged storage at room temperature or flash chromatography would contribute to 
lactam formation.  
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 To a solution of the above amine (~9.15 mmol) in anhydrous dichloromethane 
(90 mL) cooled in an ice bath N,N-diisopropylethylamine (2.80 mL, 16.07 mmol) was 
added dropwise, followed by a solution of n-butyryl chloride (1.10 mL, 11.07 mmol) in 
dichloromethane (10 mL) dropwise over 20 min. The mixture was then stirred at room 
temperature for 12 h and was washed with sodium hydroxide solution (0.5 N, 20 mL) 
and brine (20 mL x2), dried (Na2SO4), evaporated, and flash chromatographed 
(EtOAc/hexanes, 1:3) to give 3 (2.77 g, 79% for two steps) as a colorless oil. Rf = 0.28 
(EtOAc/hexanes, 1:2).  
 
Nε-Butyryl-L-lysine Hydrochloride (5) 
 To a solution of 3 (2.5 g, 7.57 mmol) in THF (30 mL) lithiumhydroxide solution 
(1.0 M, 50.0 mL, 15.0 mmol) was added, and the mixture was stirred at room 
temperature for 2 h. The mixture was diluted in water (20 mL) and extracted with ether 
(30 mL x 2). The ether extracts were discarded, and the remaining aqueous solution was 
adjusted to pH 3 with hydrochloric acid (3 N), with the concomitant formation of white 
precipitate. The suspension was extracted with ethyl acetate (60 mL x 2), and the 
combined organic phases were washed once with brine (30 mL), dried (Na2SO4), and 
evaporated to give the crude carboxylic acid as a colorless oil, which was used without 
further purification. 
  The above crude acid (~7.00 mmol) was dissolved in 1,4-dioxane (20 mL), and 
hydrogen chloride in 1,4-dioxane (4.0 M, 7.2 mL, 48.0 mmol) was added. The resulting 
white suspension was stirred at room temperature for 20 h, filtered, washed with 
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dichloromethane, and dried to give 5 (1.45 g, 76% for two steps) as a white solid. 1H 
NMR (D2O, 500 MHz) d 3.92 (t, 1H, J = 6.5 Hz), 3.04 (t, 2H, J = 6.5 Hz), 2.04 (t, 2H, J 
= 7.0 Hz), 1.84-1.75 (m, 2 H), 1.44-1.37 (m, 4 H), 1.38-1.25 (m, 2H), 0.72 (t, 3H, J = 7.0 
Hz). 13C NMR (D2O, 125 MHz) 176.8, 171.7, 52.4, 38.6, 37.3, 29.1, 27.6, 21.4, 18.9, 
12.5. The NMRs are shown in Figure IV-3 and IV-4. 
 
Synthesis of Nα-Boc-Nε-crotonoyl-L-lysine Methyl Ester (4) 
 Compound 2 (2.23 g, 5.65 mmol) was converted into the corresponding amine by 
hydrogenolysis, which was then treated with crotonyl chloride (0.81 g, 7.84 mmol) 
according to the procedure for 3 to give 4 (0.98  g, 53% for two steps) as a white oil. Rf = 
0.35 (EtOAc/hexanes, 1:2).  
 
Nε-Crotonoyl-L-lysine Hydrochloride (5)  
 According to the same procedure for 4 (1.06 g, 2.84 mmol) 5 (0.597 g, 80% for 
two steps) was afforded as a white solid 1H NMR (D2O, 500 MHz) d 6.64-6.06 (m, 1H, 
5.82 (dd, 1H, J = 1.5, 6.0 Hz), 3.92 (t, 1H, 6.0 Hz), 3.13 (t, 2H, 7.0 Hz), 1.87-1.80 (m, 
2H), 1.78 (t, 3H, J = 2.0 Hz), 1.48-1.42 (m, 2H), 1.34-1.27 (m, 2H). 13C NMR (D2O, 125 
Mhz) d 172.0, 168.8, 141.5, 123.8, 52.7, 38.6, 29.3, 27.8, 21.5, 17.1. The NMRs are 
shown in Figure IV-5 and Figure IV-6. 
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Figure IV-3. 1H NMR spectrum for Nε-butyryl-L-lysine hydrochloride. 
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Figure IV-4. 13C NMR spectrum for Nε-butyryl-L-lysine hydrochloride. 
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Figure IV-5. 1H NMR spectrum for Nε-crotonoyl-L-lysine hydrochloride. 
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Figure IV-6. 13C NMR spectrum for Nε-crotonoyl-L-lysine hydrochloride. 
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Results and Discussion 
 
Expression of Acyl-H3 Proteins and Reassembly of Acyl-Tetramer 
 Histone H3 proteins with monoacylation (either crotonylation or butyrylation) at 
sites including K4, K9, K14, K18, K23, K27, K56, and K79 were expressed and refolded 
into histone H3/H4 tetramer. The expression of crotonylated and butyrylated histone H3 
proteins in E. coli was achieved by using a mutant pyrrolysyl-tRNA synthetase 
developed in our lab with its cognate 𝑡𝑅𝑁𝐴𝐶𝑈𝐴
𝑃𝑦𝑙
.65 
 
SIRT1and SIRT2 Decrotonylation on Histone H3/H4 Tetramer 
 In our study, SIRT1 and SIRT2 demonstrated no substrate selectivity across the 
histone H3 N-terminal tail (Figure IV-7 & Table IV-1). As the enzyme reached the sites 
with more defined secondary structure (K36, K56, K79), the rate of deacylation slowed. 
This discovery largely coincides with our previous study on the deacetylase ability of 
SIRT1 and SIRT2 on acetylated nucleosomes.97 In the study, we hypothesized the cause 
of the lack of specificity for these two enzymes was tied to their spacious active site. In 
addition, both SIRT1 and SIRT2 make basic electrostatic contacts on the protein 
backbone rather than on the acetyl moiety.129, 130 For the decrotonylation of the 
crotonylated histone H3/H4 tetramer by SIRT1 and SIRT2, we apply the same logic; 
however, the results show a more logical trend this time around. The histone H3 lysine 
sites on the N-terminal tail (K4, K9, K14, K18, K23, K27) all demonstrate rapid 
decrotonylation when incubated with SIRT1 and SIRT2 at 37oC for 2 hr. The core 
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histone H3 lysine residues (K36, K56, K79); however, show a decrease in the rate of 
decrotonylation. It is possible this trend is exhibited due to the N-terminal tail lacking 
defined secondary structure, whereas the core has a defined structure, creating a more 
stringent binding environment than the former.  
 
SIRT1 and SIRT2 Debutyrylation on Histone H3/H4 Tetramer 
 Similar to our decrotonylation data, SIRT1 and SIRT2 demonstrate no substrate 
selectively on butyrylated histone H3/H4 tetramer. The same trend between N-terminal 
tail and core lysine residues is exhibited here as well (Figure IV-8 & Table IV-2). Due to 
the similar structure of crotonyllysine and butyryllysine, the expectation of similar 
results was partially expected. As mentioned earlier, since the major interactions of 
SIRT1 and SIRT2 with the substrate are on the protein backbone, the acyl modification 
likely does not affect the binding specificity. Therefore we conclude that the binding 
specificity is related to the structural conformation of the backbone at which the lysine 
site is located. 
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Figure IV-7. Western blot for SIRT1 and SIRT2 decrotonylation on histone H3/H4 
tetramer. 
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Table IV-1. Histone H3 decrotonylation with SIRT1 and SIRT2. OOO: full deacylation; 
OOX: <70% deacylation; OXX: <20% deacylation. 
 SIRT1 SIRT2 
H3K4cr OOO OOO 
H3K9cr OOX OOX 
H3K14cr OOO OOO 
H3K18cr OOO OOO 
H3K23cr OOO OOO 
H3K27cr OOO OOO 
H3K36cr OOX OOX 
H3K56cr OOX OOX 
H3K79cr OOO OXX 
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Figure IV-8. Western blot for SIRT1 and SIRT2 debutyrylation on histone H3/H4 
tetramer. 
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Table IV-2. Histone H3 debutyrylation with SIRT1 and SIRT2. OOO: full deacylation; 
OOX: <70% deacylation; OXX: <20% deacylation. 
 SIRT1 SIRT2 
H3K4bu OOO OOO 
H3K9bu OOO OOO 
H3K14bu OOO OOO 
H3K18bu OOO OOO 
H3K23bu OOO OOO 
H3K27bu OOO OOO 
H3K36bu OOX OOX 
H3K56bu OOX OOX 
H3K79bu OOX OOX 
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Conclusion and Outlook 
 
 Protein lysine butyrylation and crotonylation are two fairly new acylations 
discovered by the Yingming Zhao group in 2007 and 2011, respectively.34, 36 Beyond 
their discovery, there is a scarce amount of information related to the two acylations. 
From the data presented, we found that SIRT1 and SIRT2 demonstrate essentially no 
substrate selectively across the screened crotonylated and butyrylated histone H3 lysine 
sites. Previous evidence of sirtuin-catalyzed deacylation of crotonylation and 
butyrylation is limited to one study that found SIRT1-3 recognizes and deacylates a 
histone H3K4cr peptide.128 Our study is significant in that similar to SIRT1 and SIRT2’s 
lack of substrate specificity with acetylated histone H3 proteins, the enzyme’s lack of 
substrate specificity on histone H3 is now expanded to include two new short-chain 
acylations: butyrylation and crotonylation. 
 Recent reports have discovered that the regulation of acetyl-CoA and crotonyl-
CoA in cell are directly linked.37 Typical cellular concentrations of crotonyl-CoA in vivo 
are generally low; however, when Sabari et al. purposely downregulated acetyl-CoA 
production, the concentration of crotonyl-CoA increased. This phenomenon suggests 
that acetyl-CoA and crotonyl-CoA may have competing roles in the posttranslational 
modification of their substrates. In complement with a study by Goudarzi and coworkers 
where they found that acetylation and butyrylation compete at histone H4K8, our 
previous and most recent study on SIRT1 and SIRT2 substrate specificity may suggest 
that acetylation, crotonylation, and butyrylation are competitors for histone H3 lysine 
 114 
 
posttranslational modification.35 From the study by the Yingming Zhao group, it is 
evident that these PTMs can modify many of the same histone H3 lysine sites.34, 36 What 
determines which PTM is installed in vivo is most likely dependent on the cellular state 
or need rather than as a random occurrence. And the removal of these short-chain 
acylations can be regulated by the flexible and non-specific SIRT1 and SIRT2 enzymes. 
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CHAPTER V 
CONCLUDING REMARKS AND FUTURE OUTLOOK 
 
 In this dissertation, we developed a method for nucleosome reconstitution using 
recombinantly expressed histone H2A, H2B, H3, and a SUMO-linked H4. We also 
demonstrated the genetic incorporation of a variety of noncanonical amino acids in 
histone using the evolved PylRS/𝑡𝑅𝑁𝐴𝐶𝑈𝐴
𝑃𝑦𝑙
 pair.  
 Using the noncanonical amino acid approach, we developed a method for the 
rapid reconstitution and profiling of acetylated histone H3 nucleosomes on 96-well 
plates with SIRT1 and SIRT2. In addition, we expanded on the study by probing SIRT1 
and SIRT2 activity on crotonylated and butyrylated histone H3/H4 tetramers. From the 
studies conducted, we discovered that SIRT1 and SIRT2 demonstrate almost no 
substrate specificity for the screened histone H3 lysine sites. Our discovery suggests that 
SIRT1 and SIRT2 may naturally have no substrate specificity; instead its binding 
partners, cellular localization, and cellular state determine the enzyme’s specificity. 
 In order to further expand on our study of SIRT1 and SIRT2, we may begin to 
conduct more complex studies with SIRT1 and SIRT2 refolded with binding partners to 
see if any change in substrate specificity is seen. In addition, we can probe the substrate 
specificity of SIRT1 and SIRT2 on long-chain acylations, such as octanoylation and 
myristoylation. We can also study how different lengths of DNA wrapped around the 
nucleosome can affect SIRT1 and SIRT2 binding. Since the study of sirtuins is still in its 
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early ages of infancy, there remains much to be answered in relation to possible 
substrates, specificities, and the chemistry behind how sirtuins promote cellular health. 
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